Next Article in Journal
Design of Organoiron Dendrimers Containing Paracetamol for Enhanced Antibacterial Efficacy
Previous Article in Journal
Unraveling the Effects of Co-Crystallization on the UV/Vis Absorption Spectra of an N-Salicylideneaniline Derivative. A Computational RI-CC2 Investigation
Previous Article in Special Issue
Effect of Supplementation with Hydroethanolic Extract of Campomanesia xanthocarpa (Berg.) Leaves and Two Isolated Substances from the Extract on Metabolic Parameters of Mice Fed a High-Fat Diet

Medicinal Potential of Garcinia Species and Their Compounds

Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul-UFMS, 79070-900 Campo Grande, Brazil
Graduate of Pharmaceutical Sciences, Federal University of Mato Grosso do Sul-UFMS, 79070-900 Campo Grande, Brazil
Graduate of Electrical Engineering, Federal University of Mato Grosso do Sul-UFMS, 79070-900 Campo Grande, Brazil
Laboratory of Botany, Institute of Biosciences, Federal University of Mato Grosso do Sul, 79070-900 Campo Grande, Brazil
Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul-UFMS, 79070-900 Campo Grande, Brazil
Medical School, Federal University of Mato Grosso do Sul, 79070-900 Campo Grande, Brazil
Laboratory PRONABio (Bioactive Natural Products)-Chemistry Institute, Federal University of Mato Grosso do Sul-UFMS, 79074-460 Campo Grande, Brazil
Author to whom correspondence should be addressed.
Academic Editor: Derek J. McPhee
Molecules 2020, 25(19), 4513;
Received: 7 July 2020 / Revised: 24 July 2020 / Accepted: 30 July 2020 / Published: 1 October 2020
(This article belongs to the Special Issue Biological Activities of Medicinal Plants)


Garcinia is a genus of Clusiaceae, distributed throughout tropical Asia, Africa, New Caledonia, Polynesia, and Brazil. Garcinia plants contain a broad range of biologically active metabolites which, in the last few decades, have received considerable attention due to the chemical compositions of their extracts, with compounds which have been shown to have beneficial effects in several diseases. Our work had the objective of reviewing the benefits of five Garcinia species (G. brasiliensis, G. gardneriana, G. pedunculata, G. cambogia, and G. mangstana). These species provide a rich natural source of bioactive compounds with relevant therapeutic properties and anti-inflammatory effects, such as for the treatment of skin disorders, wounds, pain, and infections, having demonstrated antinociceptive, antioxidant, antitumoral, antifungal, anticancer, antihistaminic, antiulcerogenic, antimicrobial, antiviral, vasodilator, hypolipidemic, hepatoprotective, nephroprotective, and cardioprotective properties. This demonstrates the relevance of the genus as a rich source of compounds with valuable therapeutic properties, with potential use in the prevention and treatment of nontransmissible chronic diseases.
Keywords: Clusiaceae; phytochemical compounds; therapeutic effects Clusiaceae; phytochemical compounds; therapeutic effects

1. Introduction

Research into medicinal plants can provide essential knowledge about drugs from plants and for the production of phytotherapeutic agents. Understanding the chemical compositions of herbs is a necessary step in obtaining standards for their quality specifications, using both analytical and phytochemical determinations. Thus, materials destined for medicinal purposes must be submitted to a protocol of evaluation for their quality standards, applying all possible means of botanical and chemical analyses before commercialization [1].
The nutraceutical properties of medicinal plants can be determined by their carbohydrates, proteins, vitamins, minerals, and metabolites, such as flavonoids and antioxidants. Secondary metabolites, such as phenols and flavonoids, also contribute considerably to their medicinal functions. Fruits also have medicinal properties, their most relevant secondary metabolites being phenols and flavonoids [2].
Among medicinal plants, the former family Guttiferae, comprising circa 140 genera and 1200 species [3] (which was split into various families), and Clusiaceae, with 14 genera and 600 species, stand out. Garcinia (=Rheedia) is a plant genus of Clusiaceae, distributed throughout tropical Asia, Africa, New Caledonia, Polynesia, and Brazil. Species of Garcinia are rich and valuable sources of bioactive compounds with relevant therapeutic properties, such as anti-inflammatory and analgesic properties [4,5,6,7,8,9]. A great variety of compounds, mainly polyisoprenylated benzophenones, flavonoids, and xanthones have been isolated from Clusiaceae species. Thus, species of the genus Garcinia have proved to be rich sources of compounds with relevant therapeutical properties [7,8,10,11]. Garcinia species are rich in secondary metabolites, such as prenylated and oxygenated xanthones [11] with biological activities such as antifungal [12], anti-inflammatory [13], antitumoral [14], antioxidant [15,16], Human Immunodeficiency Virus (HIV)-inhibitory [7], and antilipidemic properties [14,17].
The genus Garcinia contains a broad range of biologically active metabolites, and these, in the last few decades, has received considerable attention for the chemical composition of their extracts, being rich in derivates of polyisoprenylated benzophenones, polyphenols, bioflavonoids, and xanthones [18,19,20].
In traditional medicine, the fruits of Garcinia have been utilized in infusions for treating wounds, ulcers, and dysentery [20]. Extracts of the pericarp, epicarp, and seeds of Garcinia have demonstrated antioxidant, anti-inflammatory, leishmanicidal, and antiprotozoal activities [21,22,23]. Another study also reported the presence of the bioflavonoids volkensiflavone, fukugetin [24], and prenylated xanthones [25]. These compounds have been associated with biological activities such as free-radical scavenging, antiulcer effects [26], cytotoxicity, inhibition of nitric oxide synthase [27], chemoprevention of cancer [28], induction of apoptosis [29], anti-HIV [30], and trypanocidal effects [31].
Some metabolites isolated from the genus Garcinia have already shown anticancer activities. Garcinol, a polyisoprenylated benzophenone obtained from Garcinia, was evaluated in vitro and in vivo, and induced apoptosis and arrest of the cellular cycle, inhibition of angiogenesis, and modulation of the gene expression of carcinogenic cells [32]. Xanthones found in Garcinia species have demonstrated effects against human cervical cancer, lung cancer cells, and hepatocellular carcinomas [33,34].
Some biflavonoids derived from Garcinia have also been evaluated for various activities, including chemoprevention properties. Among these, kolaviron has been pointed out, which presents the capacity to eliminate free radicals, inhibit proteins related to the stress response, and interfere with the DNA-binding activities of some transcription factors [35], as well as showing inhibitory activity against aromatase [36], the enzyme which catalyses the final step of the biosynthesis of estrogen, considered a key target for the development of drugs against estrogen-dependent breast cancers [37].
Given the presence of various compounds with several functions in these organisms, our work had the objective of reviewing the benefits presented by five species of Garcinia (G. brasiliensis, G. gardneriana, G. pedunculata, G. cambogia, and G. mangstana).

2. Garcinia Species and Bioactive Compounds

2.1. Garcinia Brasiliensis

Garcinia brasiliensis Mart. (Rheedia brasiliensis (Mart.) Planch. & Triana) is a species native to the Amazonian region, which is cultivated all over Brazil and which is commonly known as “bacuri”, “bacupari”, “porocó”, “bacuripari”, and, in Bolivia, “guapomo”. This tree has yellow fruit with mucilaginous, white, and edible sour-sweet pulp, which is utilized by the local people for its anti-inflammatory [22,38], antinociceptive [22], antioxidant, and antitumoral [39] properties. In some countries, such as Thailand, Sri Lanka, Malasia, the Philipines, and India, the ripe fruits are used in traditional medicine to treat abdominal pain, diarrhea, dysentery, infected wounds, suppuration, and chronic ulcers [11].
Some compounds found in the fruit peel are oxygenated sesquiterpenes—volatile oils obtained by hydrodistillation—presenting γ-muurolene (1; 10.3%), spathulenol (2; 8.7%), δ-cadinene (3; 8.3%), torreiol (4; 8.0%), α-cadinol (5; 7.0%), cadalene (6; 6.3%), and γ-cadinene (7; 5.3%) [31]. When tested, the essential oil presented anti-inflammatory activity at a dose of 100 mg/kg [22,31].
The ethanolic extract of G. brasiliensis leaves at concentrations of 30 and 300 mg/kg demonstrated anti-inflammatory action in rats and antinociceptive action in mice, corroborating the traditional use of species of Garcinia against inflammation of the urinary tract and inflammatory pains such as arthrosis. The biflavonoids procyanidin (8), fukugetin (9), amentoflavone (10), and podocarpusflavone A (11), isolated from G. brasiliensis, represent a therapeutic strategy to control diseases related to oxidative stress, controlling inflammation and reducing the harmful effects of reactive species of oxygen (ROSs). Furthermore, biflavonoids have exhibited potent inhibition of the oxidative hemolysis and lipidic peroxidation induced by 2,2′-azobis amidinopropane (AAPH) in human erythrocytes, demonstrating the anti-inflammatory and antioxidant properties of the compounds present in G. brasiliensis [40].
Another effect presented by the species is leishmanicidal activity [21,41]. The leishmanicidal activities of the hexane extract and ethyland ethanolic acetate at 5.0 mg/mL were evaluated, as well as those of molecules obtained from the extraction of the pericarp of G. brasiliensis in an in vitro model. The hexane extract presented the best activity on extracellular (promastigote) and intracellular (amastigote) forms of Leishmania (L.) amazonensis, compared with other extracts. Following those results, fractions of the most efficient extract were made, resulting in three purified prenylated benzophenones, 7-epi-clusianone (12), garciniaphenone (13), and guttiferone-a (14) [21,42]. These results suggested that the hexane extract and the polyprenylated benzophenones isolated from G. brasiliensis have relevant leishmanicidal activities and provide potential compounds for the development of new drugs against leishmaniasis. The compound found in the extract, morelloflavone-7,4′,7′′,3′′′,4′′′′-penta-O-acetyl (15), was prepared by acylation and alkylation reactions from the compound morelloflavone isolated from the ethyl acetate extract of G. brasiliensis fruits, which demonstrated leishmanicidal, antiproteolytic, and antioxidant activities, as well as low cytotoxicity in in vitro models, at a concentration of 400 μg/mL [41].
The compound 7-epiclusianone (12) found in the pericarp of G. brasiliensis fruits exhibited biological activity in vitro against trypomastigotes of Trypanosoma cruzi [9], and a potent vasodilatory effect on the endothelium [42]; antianaphylactic [43], anti-HIV [29], antimicrobial [5,44,45,46], antispasmodic [39], antiproliferative [45], and leishmanicidal activities, have also been attributed to this benzophenone [21].
A study evaluated the analgesic and anti-inflammatory effects of benzophenone 7-epiclusianone extracted from the epicarp of G. brasiliensis using experimental models of rats and mice [22]. In the test, benzophenone 7-epiclusianone (12) exerted an anti-inflammatory effect, which was verified through the reduction of mouse paw edema induced by carrageenin and the inhibition of recruitment of leucocytes to the peritoneal cavity, as well as the nociception induced by intraperitoneal injection of acetic acid. The substances associated with the extract components were capable of absorbing ultraviolet-B (UVB) radiation, preventing the induced inflammatory process. The absorption of UVB radiation by components of the ethanolic extract could impede the installation of oxidative stress and, consequently, lipidic peroxidation, antioxidant capacity, and removal of free radicals, contributing to a photoprotective effect [47].
Treatment with 7-epiclusianone (12) altered the cell-cycle progression; furthermore, the capacity to form cell colonies was significantly reduced, demonstrating long-term effects. This demonstrated that 7-epiclusianone (12) is a relevant natural benzophenone with antineoplastic activity in a model of glioblastoma—a tumor with chemoresistance, demonstrating influence on growing cells, cell-cycle dynamics, apoptosis, and ability to form colonies [48]. The 7-epiclusianone (12) was isolated from G. brasiliensis for the treatment of schistosomiasis, showing efficacy against Schistosoma mansoni adult worms, cercariae, and schistosomula in vitro [49].
Administration of the ethanolic extract to rats at a concentration of 300 mg/kg produced an increased antioxidant activity through the reduction of inflammation and adiposity in obese rats. The antiobesity effect of the treated group was related to the negative regulation of the lipogenic gene of the lipoprotein lipase (LPL), the proteins of Tumor Necrosis Factor Alpha (TNF-α) and Interleukin 1 (IL-1), diminishing adipogenesis, adipocyte size, and body weight, when compared with the control group [50].
The following components have been isolated from the epicarp of G. brasiliensis fruit: a new glycosylated biflavonone, morelloflavone-4′′′-O-β-d-glycosyl (16), and the known compounds 1,3,6,7-tetrahydroxyxanthone (norathyriol; 17), morelloflavone (fukugetin; 9), and morelloflavone-7′′-O-β-d-glycosyl (fukugesid; 18). These compounds presented antioxidant activity after the isolation of natural biflavonoids from the plant [41].
The ethanolic extract of G. brasiliensis, at a concentration of 300 mg/kg, reduced oxidative stress and inflammation in obese rats with cardiac insufficiency, and presented a promising strategy for beneficial microbiota modulation. That demonstrates the potential protective effects of two phenolic compounds, morelloflavone and 7-epiclusianone (12), present in the extract [51].
It is worth noting the method of extraction of the bioactive compounds. The use of the solvent N-hexane has demonstrated to be the most adequate for extracting guttiferone A and/or 7-epiclusianone, whereas the highest levels of fukugetin and norathyriol (17) were detected in the ethyl acetate fraction [37]. Table 1 and Figure 1 summarize the main compounds, plant part from which they were extracted, and their related activities.

2.2. Garcinia Gardneriana

Garcinia gardneriana (Planch. & Triana) Zappi (Rheedia gardneriana Planch. & Triana) (Clusiaceae) is native to the Atlantic forest and grows throughout Brazil. It is an easily cultivated fruit tree which is often found in domestic orchards. It is regionally known as “bacupari”, “bacopari”, “bacopari-miúdo”, or “mangostão-amarelo” [53]. The fruit is initially dark green, becoming yellowish-green or yellow-orangish when ripe. The fruit peel (or epicarp) is smooth and coriaceous. The pulp is white, edible, and sour-sweetish, formed by the mesocarp and endocarp [52,54]. A study on its fruits identified two phytosterols—sitosterol and stigmasterol—which have already presented anti-inflammatory and anticancer activities in other studies, with the isolation of these compounds achieved in fruits of the genus Garcinia [37,52]. Furthermore, four sesquiterpenes—α-copaene (19), α-muurolene (20), γ-cadinene (7), and cadinene (21)—were identified in the fruit peel, besides triterpene oleanolic acid (22) [52].
The plant has generally been applied for several purposes in folk medicine, such as inflammatory problems including skin disorders and wounds, as well as for the treatment of pain and infections [38]. The leaves, bark, and roots are the most utilized parts, typically prepared as infusions, decoctions, or macerates, either separately or combined with other natural products [38].
Evaluation of a hydroalcoholic extract of G. gardneriana revealed that it diminished the quantity of melanin in B16F10 melanoma cells and, specifically, promoted the inhibition of tyrosinase activity [55]. The ethanolic extract conferred an additional beneficial effect to the skin as the plant has a high content of bioflavonoids, which are considered to be able to reduce the potential oxidative damage produced in the skin after exposure to ultraviolet radiation [56]. G. gardneriana presented a potential source of bioactive compounds with a significant antiproliferative effect in breast neoplastic lines in animals [57].
Garcinia gardneriana is very rich in secondary metabolites. Some phytochemical analyses have identified xanthones, steroids, triterpenes, and flavonoids in different parts of the plant [14,41,42,43], which have been associated with pharmacological effects such as anti-inflammatory, antinociceptive, antibacterial, and antiparasitic activities [38,58,59,60].
Phytochemical analyses of G. gardneriana detected several classes of compounds, such as steroids, triterpenes, biflavonoids, and xanthones [61]. Several biflavonoids found and identified as volkensiflavone (23), 13-naringenin-II 8-eriodictyol (GB-2a; 24), fukugetin (or morelloflavone; 9), and fukugesid (18) have demonstrated analgesic effects [62]. A new biflavonoid isolated from G. gardneriana leaves, named GB2a-OMe (25), also presented a significant analgesic effect in the formalin test in mice in the neurogenic and inflammatory phases [63].
The compound GB-2a significantly inhibited the melanin content without reducing cell viability, suggesting its great potential for medical use as a hypopigmentation agent, for cosmetic and clinical applications related to skin clearing [64]. The compound fukugetin (or morelloflavone) showed an anti-inflammatory activity in mouse paw edema induced by carrageenin at a concentration of 300 mg/kg, rendering the plant a potential target for the development of new compounds to be explored as alternatives to drugs with anti-inflammatory activity that are already in use [65].
The biflavonoids isolated from G. gardneriana, such as morelloflavone (9), Gb-2a (24), and Gb-2a-7-O-glucose (26) were submitted to an in vitro trial in order to evaluate their modulatory effects on aromatase, utilized for cancer treatment. The results showed that all biflavonoids were able to inhibit the enzyme, with IC50 values varying from 1.35 to 7.67 μM. This demonstrates that these biflavonoids are a relevant source of new aromatase inhibitors, with focus on the development of new anticancer agents. This reinforces that the species is an important source of bioactive compounds, with applications concentrated mainly in the treatment of estrogen-dependent breast cancers [65]. Table 2 and Figure 2 summarize the main compounds of Garcinia gardneriana, the plant parts from which they were extracted, and their related activities.

2.3. Garcinia Pedunculata

Garcinia pedunculata Roxb. (Clusiaceae) is a tree endemic to some Asian regions—namely to parts of Myanmar and oriental parts of India. The fruit is known as “taikor” in Bangladesh and “amlavetasa” in India [66]. It also is an indigenous medicinal plant. Traditionally, the fruit has been utilized by people to treat several gastrointestinal disorders [67], as a cardiotonic, and as an emollient. It is also utilized in the treatment of asthma, cough, bronchitis, diarrhea, and fever [68].
The fruit is greenish-yellow and is utilized as an ingredient in several meat dishes as a culinary adstringent [69]. The fruit of G. pedunculata contains 7.93% carbohydrates, 0.95% reducing sugars, 4.93% total proteins, and 0.20% total fats. Regarding the composition of vitamins and minerals, it has 2.48 mg/100 g sodium, 27.3 mg/100 g potassium, 13.21 mg/100 g calcium, 35.43 mg/100 g magnesium, 10.12 mg/100 g iron, 4.32 mg/100 g phosphorus, 49 µg/100 g thiamine, 276 µg/100 g riboflavin, 47 µg/100 g niacin, 35.43 µg/100 g ascorbic acid, and 8.12 µg/100 g vitamin B12 [2].
Phytochemical studies have shown that the dry fruits contain hydroxylcitric acid, benzophenones, garcinol, pedunculol, and isogarcinol (cambogin), the first having been reported as possessing antioxidant activity [16], and the second and third with anticancer, anti-inflammatory, and antiparasitic activities [24,70]. Dry fruits have been selected for different actions and have shown anti-inflammatory, hepatoprotective, cardioprotective, and antioxidant pharmacological activities in vitro [71,72]. Phytochemical analyses have revealed the presence of phytochemicals such as pedunculol (27), garcinol (28), cambogin (29) [73], and (α)-hydroxylcitric acid (30) [70]. Hexane and chloroform extracts of Garcinia pedunculata showed antioxidant activity, helping in the elimination of free radicals and showing strong antimutagenicity, the hexane extract being more reactive than that of the chloroform extract [73].
Among the reported benefits of G. pedunculata fruit are antioxidant [70,71,72,73,74,75], antimicrobial [76], anti-inflammatory [71], hypolipidemic [77], hepatoprotective [66], and nephroprotective effects [71], as well as cardioprotective properties [77]. The peel and the pericarp of dry fruits have been shown to contain benzophenones, pedunculol (27), garcinol (28), cambogin (29), and hydroxycitric acid (HCA; 30) [70], some of which are potent antioxidants. Some research has suggested that benzophenones and garcinol present protective effects against the toxicity of carbon tetrachloride in hepatocytes of rats [70] and anti-inflammatory effects in hepatocytes of mice [78]. An ethanolic extract of the fruit showed significant hepatoprotective, cardioprotective, and hypoglycemic activities in the treatment of Long Evans rats with a daily dose of 1000 mg/kg for 21 days [79]. The nephroprotective effect detected with the administration of a water extract of the fruit peel at concentrations of 200 and 400 mg/kg of weight was attributed to its general cytoprotective effect, which promptly impeded the ischemic damage caused by acute toxicity by cisplatin, a cytotoxic agent that has effects on the kidneys, liver, and neural tissues [80].
Administration of the extract of G. pedunculata fruit significantly reduced blood glucose levels, demonstrating the possibility of reduction of hyperglycemia, diabetes, diabetic comorbidities, and protection against damages induced by oxidative stress [81]. Administration of methanolic extract at a concentration of 200 mg/kg attenuated hyperlipidemia and oxidative stress in the studied animals [77]. Evaluation of a methanolic extract of the fruit showed antioxidant activity, having free-radical scavengers and the capacity to protect cells from lipidic peroxidation, which is associated with the treatment of degenerative diseases and diabetes [77,82].
A recent study on an aqueous extract of fruits of G. pedunculata given to rats at 200 and 400 mg/kg of body weight observed a significant reduction in damage caused by colitis, preventing oxidative peroxidation. At the dose of 400 mg/kg, the lipidic peroxidation was reverted significantly, and in several parameters of inflammation generated in the colon showed improvement (i.e., the punctuation of macroscopic damage, lipidic peroxidation, and histopathological exam of the colon tissue), demonstrating its therapeutical potential for the treatment of colitis [83].
Analysis of pericarp and peel separately reported a diversity of xanthones in the form of the compounds peduxanthone-d (31), -E (32), and –F (33), standing out in the pericarp [33], which have shown anticancer activity [65]; meanwhile, garbogiol (34), present in the peel [33], has been reported as an inhibitor of α-glucosidase [33].
Besides the fruits, a study on the heartwood of the species [19] identified benzophenone2,4,6,3′,5′-pentahydroxybenzophenone (35) and the xanthones 1,3,6,7-tetrahydroxyxanthone (36) and 1,3,5,7-tetrahydroxyxanthone (37) to have antioxidant activity [42] and LDL-c-oxidation-inhibitory activity, respectively; additionally, the biflavonoids GB-1a (38) and volkensiflavone (23) have shown antioxidant activity [84] and antitumoral activity [74], respectively. Table 3 and Figure 3 summarize the main compounds, the plant parts they have been extracted from, and their related activities.

2.4. Garcinia Cambogia

Garcinia cambogia L., known as Malabar tamarind, is a plant native to Southeast Asia. The fruit is used as a food preservative, carminative, and flavoring agent [82]. The fruit contains hydroxycitric acid (HCA; 30) and is a popular ingredient utilized for weight reduction [85,86]. Semwal [85] presented a revision of the species, citing the presence of organic acids, such as HCA, in the fruits, as well as the xanthones oxy-guttiferone-I (40), -K (41), -K2 (42), and -M(43), and the benzophenones guttiferone-I (44), -J (45), -K (46), -N(47), and -M (48). Guttiferone-K (46) and guttiferone-M (48) are inhibitors of topoisomerase II [87]. In that same study, the presence of the xanthone garbogiol was reported in the roots. In the peel, the presence of rheediaxanthone-A [86], benzophenonesgarcinol (28), and isogarcinol (29) was also reported.
In Indian medicine, the extract of G. cambogia is used to treat ulcers, hemorrhoids, diarrhea, dysentery, and some types of cancer, such as leukemia [88]. Initial studies on seeds confirmed that they have antifungal [89], anticancer [28,90], antihistaminic [91], antiulcerogenic [92], antimicrobial [93], antiviral [94], and vasodilatory effects [95]. The gastroprotective effects seem to be related to its capacity to diminish acidity and increase the mucosal defenses [92,96]. Furthermore, the extract presented hypolipidemic [95], antiadipogenic, and appetite-suppression effects in experimental animals through the inhibition of the expression of the early adipogenic transcription factor CCAAT enhancer-binding protein alpha (C/EBP alpha), which regulates adipogenesis [97,98,99].
The hypolipidemic effect of the G. cambogia extract has been attributed to its high content of flavonoids [100]. The generated anti-inflammatory effects resulted in the improvement of some parameters analyzed in experimental colitis, where 2,4,6-Trinitrobenzenesulfonic acid (TNBS)/ethanol caused lesions characterized by severe necrosis of the mucosa, hyperemia, and focal adhesion to adjacent organs. Administration of the extract by oral gavage at a dose of 1.0 g/kg reduced the length of the lesions observed macroscopically; thus, it may provide a source to search for new anti-inflammatory compounds useful in the treatment of intestinal inflammatory diseases [101].
Garcinia cambogia showed an antiobesity effect and a significant reduction in the values of triacylglycerol (TAG) of the adipose tissue and liver of the tested groups; however, it significantly increased the TAG pool of the gastrointestinal system [95,102,103]. The plant also reduced the serum levels of total cholesterol, triglycerides, and insulin, as well as the intolerance of glucose and levels of alpha-TNF associated with hyperlipidic diets [95,102,103,104,105]. G. cambogia extracts have also been shown to trigger the myotubes and skeleton cells to absorb glucose and to equilibrate the glucose levels in the blood [106].
This species also has already shown favorable results in tests in humans—either healthy or bearing some nontransmissible chronic disease—for 6 months. Treatment with 500 mg of HCA, twice a day, promoted weight loss and reduction of fatty mass, visceral fat, total cholesterol, and glycemic profile. Furthermore, an increase of the basal metabolic rate was perceived, independent of sex, age, or bearing hypertension, diabetes mellitus type 2, or dyslipidemia [107].
The HCA (30) present in G. cambogia is a potent and competent inhibitor of adenosinetriphosphate (ATP) citrate lyase, which is a key enzyme in the synthesis of fatty acids, cholesterol, and triglycerides [85,108]. It also regulates the level of serotonin, which has been associated with satiety, increased oxidation of fat, and decreased gluconeogenesis [85,109]. This explains how the compound exerts weight-loss activity, with reduced food ingestion and reduction of accumulated gain of body fat [85,108,109,110]. HCA (30) presents a chemical structure similar to citric acid and, therefore, inhibits the action of adenosine triphosphate (ATP) citrate lyase in the citric acid cycle. This action inhibits the conversion of citric acidinacetyl-coenzyme A (CoA) and suppresses the synthesis of fatty acids. The increased quantity of citric acid that is not converted into acetyl-CoA leads to acceleration of the production of glycogen from glucose. Thus, the ingestion of HCA (30) stabilizes glucose levels in the blood, resulting in the suppression of feelings of hunger. Therefore, it is also expected to show a preventive effect against hyperphagia [111,112,113,114,115]. Earlier studies showed that HCA (30) reduced the build-up of lipidic droplets and accelerated the energy metabolism, besides protecting cells from oxidative stress, as well as increasing the antioxidant status and mitochondrial functions [116,117].
Despite the benefits present in the species, some studies have shown that its consumption can cause adverse effects, such as headache, dizziness, dry mouth, nausea, and diarrhea [118]. Recent studies have described (hypo)mania and/or psychosis after the consumption of G. cambogia [87,119,120,121]. Some liver complications have also been reported, such as hepatotoxicity, with acute hepatic lesions, acute hepatitis, and hepatic insufficiency requiring transplant [122,123,124,125]. The complications from G. cambogia include mania or hypomania, mania with psychosis, and serotonin syndrome [10,126]. When taken over the recommended dose, individuals should be aware that the extract of G. cambogia can also lead to ocular complications [127].
HCA (30), the main active ingredient of G. cambogia extracts, presents effects of inhibiting the recapture of serotonin, inhibiting acetylcholinesterase, increasing the oxidation of fatty acids, and reducing lipogenesis [85]. The serotoninergic effects of HCA (30) are worrisome and can contribute to serotonin syndrome when combined with serotonin recapture inhibitors [109].
Some cases have been reported of acute pancreatitis secondary to the use of G. cambogia [128,129]. The pathogenesis of how such an increased risk of acute pancreatitis may occur is not clear; however, there is evidence that active oxygen species may play a central role in this pathogenesis. Garcinia cambogia increases lipidic peroxidation and positively regulates the expression of superoxide dismutase and glutathione peroxidase messenger ribonucleic acid (RNA) [130]. Lipidic peroxidation also increases oxidative stresss and can increase the risk of acute pancreatitis in patients using the species [131]. G. cambogia can cause other severe adverse events, including hepatoxicity and secondary acute hepatic insufficiency [124,132]. Other studies have also shown acute necrotizing eosinophilic myocarditis, rhabdomyolysis, serotonin toxicity, and nephropathy secondary to the use of G. cambogia [87,121,122,128,129,130,131,132,133,134,135,136]. Table 4 and Figure 4 describe the main compounds, the plant parts they have been extracted from, and their related activities.

2.5. Garcinia Mangostana

Garcinia mangostana L. is a tropical evergreen fruit tree native to Southeast Asia, with the popular name of mangosteen, known for containing several constituents including xanthones, flavonoids, triterpenoids, and benzophenones [64]. In many Asian countries, the peel of G. mangostana has been used in traditional medicine to cure various diseases, such as diarrhea, dysentery, skin infections, mycosis, inflammation, cholera, and fever [139,140]. Fruit extracts have exhibited antioxidant [141,142], anti-inflammatory [143,144], antibacterial [145], and antidepressive effects [146]. In particular, α-mangostin (AM; 49), a primary component of G. mangostana, has presented substantial pharmacological properties [147,148], including antioxidant activity in the treatment of age-related macular degeneration and protecting the retina from light damage [149].
Its pharmacological properties have been attributed to the presence of polyphenols such as xanthones, anthocyanins, phenolic acids, and flavonoids [142,150]. It has demonstrated antioxidant, anti-inflammatory, antitumoral, antibacterial, antifungal, antiviral, and anti-allergic properties [150,151]. Alfa-mangostin (49) is one of the most abundant xanthones in G. mangostana. The presented anti-inflammatory effects have been evidenced by reduced levels of TNF-α and IL-6 [152,153]. It has also shown antihyperglycemic, antioxidant, and anti-inflammatory effects, as well as improved blood flux and integrity of the retina [153,154]. The fruit has also produced improved results in terms of adiposity, hyperlipidemia, insulin resistance, and hepatic lesion related to ageing [155].
Mangosteen is used, in the form of an infusion, as a tonic for fatigue and as a digestive [139]. It can also be utilized for its medicinal properties in hemorrhoids, flood allergies, arthritis, tuberculosis, mycosis, mouth sores, fever, candidiasis, abdominal pain, suppuration, leucorrhea, and convulsions [140].
Some studies have shown the antihyperglycemic power and antidiabetic activity of mangosteen. Mangosteen pericarp extract has shown efficacy in the reduction of cholesterol levels and lipidic peroxidation, besides improving the kidney structure and function in fastening diabetic rats [156,157]. The hypoglycemic power is due to the inhibition of the activity of α-glucosidase and α-amylase: the enzymes responsible for the digestion of carbohydrates [158]. The xanthones mangostaxanthone-I (50), -II (51), and -VIIII (52), found in the pericarp, have been reported as inhibitors of the activity of α-amylase [133]; meanwhile, mangostenone-F (53), gartanin (54), α-magostin (49), and γ-magostin (55) have been shown to be inhibitors of the activity of α-glucosidase. Besides these compounds, the presence of the xanthones β-magostin (56), 3-isomangostin (57), magostenone-C (58) and -d (59), as well as the flavonoids aromadendrin-8-C-β-d-glucopyranoside (60) and epicatechin (61), in the fruits corroborates those studies, which have presented hypoglycemic and antiobesity activities [134].
A hepatoprotective effect, which has previously been shown as one of the actions of α-mangostin [159], and renoprotective action were also found in streptozotocin-induced diabetic mice [160]. Some authors have cited the compound α-mangostin (49) as having anticancer activities, being capable of inducing cell death via apoptosis of human colorectal carcinomas [161,162]. This compound has presented antioxidant activity and evidences the benefits of the fruit in improving the kidney structure and function in diabetic rats [157]. In human melanoma, breast cancer, and epidermoid carcinoma, the compound α-mangostin had a cytotoxic effect, inducing the death of the cited cells [163,164].
One study on the mangosteen pericarp demonstrated a wide range of activities, including antifungal, antioxidant, antiobesity, and antidiabetic properties [139]. Its hypoglycemic power is due to the inhibition of the activity of α-glucosidase and α-amylase, enzymes responsible for the digestion of carbohydrates [158].
Some studies have presented satisfactory results with respect to the endogenous antioxidant system, demonstrating a high level of antioxidant enzymes in the organisms of the tested animals. Such effects suggest the capacity of the fruit to eliminate free radicals from the biological system [165]. Human adipocytes treated with α-mangostin (49) showed a decrease in the expression of inflammatory genes, as well as reducing insulin resistance [166]. Indeed, the daily consumption of a mangosteen drink for 30 days in healthy adults resulted in reduction of the inflammatory markers and increased the antioxidant capacity of human blood, due to reduction of the inflammatory marker C-reactive protein, reducing the risk of inflammation and chronic diseases related to immunity [167]. Thus, it has been proven that the mangosteen is a plant which can provide benefits in the development of drugs for the prevention and treatment of numerous diseases, mainly as it is a rich source of xanthones and other bioactive substances [159].
A study on rats fed daily with an aqueous extract of mangosteen pericarp (100 and 200 mg/kg, 38 days) showed that they exhibited significant improvements in memory loss. The extract, rich in xanthones, was also capable of restoring acetylcholinesterase activity in the dysfunction induced by lead in red blood cells and brain tissue. The presence of the xanthones α- and γ-mangostin (55), 3-isomangostin (57), gartanin (54), garciniafuran (62), 9-hydroxycalabaxanthone (63), and garcinone -C (64) and -d (65) was verified [134]. Table 5 and Figure 5 list the main compounds of Garcinia mangostana, the plant part where they have been extracted from, and their related ativities.

3. Conclusions

Plant species of the genus Garcinia are a relevant source of bioactive compounds. This review compiled the bioactive compounds found in five species of the genus Garcinia, as well as the effects of several types of extracts of different plant parts. Plants from genus Garcinia exhibits healing properties with anti-inflammatory effects, for the treatment of such ailments as skin disorders, wounds, pain, and infections, as well as presenting antinociceptive, antioxidant, antitumoral, antifungal, anticancer, antihistaminic, antiulcerogenic, antimicrobial, antiviral, vasodilatory, hypolipemic, hepatoprotective, nephroprotective, and cardioprotective properties. It was possible to observe that, across all the species mentioned in the present review, most of the studies carried out were in vitro experiments. Some tests have already been started in in vivo models; however, these are recent studies evaluating the effectiveness of the plant in treating diseases in animal models. These studies are promising and open up new perspectives on the use of the compounds present in these species, offering new perspectives on the possibility of developing new drugs. For this to be effective, it is necessary to initiate plant-use tests in humans, in order to analyze their effectiveness in treating diseases. Therefore, considering the high number of compounds found in plants of the genus and their beneficial effects, additional studies are required to support the development of new products with therapeutic properties for the prevention and treatment of various diseases; most importantly, non-transmissible chronic diseases. Therefore, these plants provide a promising potential source of natural biomolecules for pharmaceutical and medicinal applications.

Author Contributions

B.L.S.d.E.S., L.F.S., F.d.O.d.A.; P.A.H.; and M.A.A.: writing—original draft preparation; W.H.K.J., D.B., K.d.C.F., R.d.C.A.G., A.P., W.F.d.O.F., P.d.O.F. and P.R.H.d.O.B.: writing—review and editing. All authors have read and agreed to the published version of the manuscript.


This work was carried out with support from the Federal University of Mato Grosso do Sul-UFMS/MEC-Brazil. This study was financed, in part, by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES); FinanceCode 001.


Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul-UFMS.

Conflicts of Interest

The authors declare no conflict of interest.


  1. Kunle, O.F.; Egharevba, H.O.; Ahmadu, P.O. Standardization of herbal medicines—A review. Int. J. Biodivers. Conserv. 2012, 4, 101–112. [Google Scholar] [CrossRef]
  2. Shameer, P.S.; Rameshkumar, K.B.; Mohanan, N. Diversity of garcinia in the Western Ghats. Phytochemical perspective. India Jawaharlal Nehru Trop. Bot. Gard. Res. Inst. 2016, 1–18. [Google Scholar]
  3. Ampofo, S.A.; Waterman, P.G. Xanthones and neoflavonoids from two Asian species of Calophyllum. Phytochemistry 1986, 25, 2617–2620. [Google Scholar] [CrossRef]
  4. Monache, G.D.; Monache, F.D.; Waterman, P.G.; Crichton, E.G.; De Lima, R.A. Minor xanthones from Rheedia gardneriana. Phytochemistry 1984, 23, 1757–1759. [Google Scholar] [CrossRef]
  5. Almeida, L.S.B.; Murata, R.M.; Yatsuda, R.; Dos-Santos, M.H.; Nagem, T.J.; Alencar, S.M.; Koo, H.; Rosalen, P.L. Antimicrobial activity of Rheedia brasiliensis and 7-epiclusianone against Streptococcus mutans. Phytomedicine 2008, 15, 886–891. [Google Scholar] [CrossRef]
  6. Panthong, A.; Norkaew, P.; Kanjanapothi, D.; Taesotikul, T.; Anantachoke, N.; Reutakul, V. Anti-inflammatory, analgesic, and antipyretic activies of the extract of gamboge from Garcinia hanburyi Hook. J. Ethnophamacol. 2007, 111, 335–340. [Google Scholar] [CrossRef]
  7. Gustafson, K.R.; Blunt, J.W.; Munro, M.H.G.; Fuller, R.W.; McKee, T.C.; Cardellina, J.H.; McMahon, J.B.; Cragg, G.M.; Boyd, M.R. The guttiferones, HIV-inhibitory benzophenones from Symphonia globulifera, Garcinia livingstonei, Garcinia ovalifolia and Clusiarosea. Tetrahedron 1992, 48, 10093–10102. [Google Scholar] [CrossRef]
  8. Williams, R.B.; Hoch, J.; Glass, T.E.; Evans, R.; Miller, J.S.; Wisse, J.H.; Kingston, D.G.I. A novel cytotoxic guttiferone analogue from Garcinia macrophylla from the Suriname Rainforest. Planta Med. 2003, 69, 864–866. [Google Scholar]
  9. Almeida-Alves, T.M.; Oliveira-Alves, R.; Romanha, A.J.; Santos, M.H.; Nagem, T.J.; Zani, C.L. Biological activities of 7-epiclusianone. J. Nat. Prod. 1999, 62, 369–371. [Google Scholar] [CrossRef]
  10. Nguyen, D.C.; Timmer, T.K.; Davison, B.C.; McGrane, I.R. Possible garcinia cambogia-induced mania with psychosis: A case report. J. Pharm. Pr. 2017, 32, 99–102. [Google Scholar] [CrossRef]
  11. Cui, J.; Hu, W.; Cai, Z.; Liu, Y.; Li, S.; Tao, W. New medicinal properties of mangostins: Analgesic activity and pharmacological characterization of active ingredients from the fruit hull of Garcinia mangostana. Pharm. Biochem. Behav. 2010, 95, 166–172. [Google Scholar] [CrossRef] [PubMed]
  12. Sordat-Diserens, I.; Rogers, B.S.C.; Hostettmann, K. Prenylated xanthones from Garcinia livingstonei. Phytochemistry 1992, 31, 313–316. [Google Scholar] [CrossRef]
  13. Khanum, S.A.; Shashikanth, S.; Deepak, A.V. Synthesis and anti-inflammatory activity of benzophenone analogues. Bioorg. Chem. 2004, 32, 211–222. [Google Scholar] [CrossRef] [PubMed]
  14. Diaz-Carballo, D.; Seeber, S.; Strumberg, D.; Hilger, R.A. Novel antitumoral compound isolated from Clusiarosea. Int. J. Clin. Pharm. 2003, 41, 622–623. [Google Scholar] [CrossRef]
  15. Merza, J.; Aumond, M.C.; Rondeau, D.; Dumontet, V.; Le Ray, A.M.; Seraphin, D.; Richomme, P. Prenylated xanthones and tocotrienols from Garcinia virgata. Phytochemistry 2004, 65, 2915–2920. [Google Scholar] [CrossRef]
  16. Mundugaru, R.; Narayana, S.K.K.; Ballal, S.R.; Thomas, J.; Rajakrishnan, R. Neuroprotective activity of Garcinia pedunculata roxb ex buch ham fruit extract against aluminium chloride induced neurotoxicity in mice. Indian J. Pharm. Educ. Res. 2016, 50, 435–441. [Google Scholar] [CrossRef]
  17. Hay, A.E.A.; Mallet, M.C.; Dumontet, S.; Litaudon, V.; Rondeau, M.; Richomme, D. Antioxidant xanthones from Garcinia vieillardii. J. Nat. Prod. 2004, 67, 707–709. [Google Scholar] [CrossRef]
  18. Bennett, G.J.; Lee, H.K. Xanthones from Guttiferae. Phytochemistry 1989, 28, 967–998. [Google Scholar] [CrossRef]
  19. Rao, A.V.R.; Sarma, M.R.; Venkataraman, K.; Yemul, S.S. A benzophenone and xanthone with unusual hydroxylation patterns from the heartwood of Garcinia pedunculata. Phytochemistry 1974, 13, 1241–1244. [Google Scholar] [CrossRef]
  20. Acuña, U.M.; Dastmalchi, K.; Basile, M.J.; Kennelly, E.J. Quantitative high performance liquid chromatography photo-diode array (HPLC–PDA) analysis of benzophenones and biflavonoids in eight Garcinia species. J. Food. Compos. Anal. 2012, 25, 215–220. [Google Scholar] [CrossRef]
  21. Pereira, I.O.; Marques, M.J.; Pavan, A.L.R.; Codonho, B.S.; Barbiéri, C.L.; Beijo, L.A.; Doriguetto, A.C.; D’Martin, E.C.; dos Santos, M.H. Leishmanicidal activity of benzophenones and extracts from Garcinia brasiliensis Mart. Fruits. Phytomedicine 2010, 17, 339–345. [Google Scholar] [CrossRef]
  22. Santa-Cecília, F.V.; Vilela, F.C.; da Rocha, C.Q.; Dias, D.F.; Cavalcante, G.P.; Freitas, L.A.; dos Santos, M.H.; Giusti-Paiva, A. Anti-inflammatory and antinociceptive effectsof Garcinia brasiliensis. J. Ethnopharmacol. 2011, 133, 467–473. [Google Scholar] [CrossRef]
  23. Martins, F.T.; Doriguetto, A.C.; de Souza, T.C.; Souza, K.R.; Santos, M.H.; Moreira, M.E.; Barbosa, L.C. Composition, and anti-inflammatory and antioxidant activities of the volatile oil from the fruit peel of Garcinia brasiliensis. Chem. Biodivers. 2008, 5, 251–258. [Google Scholar] [CrossRef]
  24. Botta, B.; Mac-Quhae, M.M.; Delle-Monache, G.; Delle-Monache, F.; De Mello, J.F. Chemical investigation of the genus Rheedia. V. Biflavonoids and xanthochymol. J. Nat. Prod. 1984, 47, 1053. [Google Scholar] [CrossRef]
  25. Schobert, R.; Biersack, B. Chemical and biological aspects of garcinol and isogarcinol: Recent developments. Chem. Biodivers. 2019, 16, 1–13. [Google Scholar] [CrossRef] [PubMed]
  26. Yamaguchi, F.; Saito, M.; Ariga, T.; Yoshimura, Y.; Nakazawa, H. Free radical scavenging activity and antiulcer activity of garcinol from Garcinia indica fruit rind. J. Agric. Food Chem. 2000, 48, 2320–2325. [Google Scholar] [CrossRef] [PubMed]
  27. Cruz, A.J.; Lemos, V.S.; Santos, M.H.; Nagem, T.J.; Cortes, S.F. Vascular effects of 7-epiclusianone, a prenylated benzophenone from Rheedia gardneriana, on the rat aorta. Phytomedicine 2006, 13, 442–445. [Google Scholar] [CrossRef]
  28. Ito, C.; Itoigawa, M.; Miyamoto, Y.; Onoda, S.; Sundar, R.K.; Mukainaka, T.; Tokuda, H.; Nishino, H.; Furukawa, H. Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities. J. Nat. Prod. 2003, 66, 206–209. [Google Scholar] [CrossRef]
  29. Pan, M.; Chang, W.; Lin-Shiau, S.; Ho, C.; Lin, J. Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J. Agric. Food Chem. 2001, 49, 1464–1474. [Google Scholar] [CrossRef]
  30. Piccinelli, A.L.; Cuesta-Rubio, O.; Chica, M.B.; Mahmood, N.; Pagano, B.; Pavone, M.; Barone, V.; Rastrelli, L. Structural revision of clusianone and 7-epi-clusianone and anti-HIV activity of polyisoprenylated benzophenones. Tetrahedron 2005, 61, 8206–8211. [Google Scholar] [CrossRef]
  31. Abe, F.; Nagafuji, S.; Okabe, H.; Akahane, H.; Estrada-Muñiz, E.; Huerta-Reyes, M.; Reyes-Chilpa, R. Trypanocidal constituents in plants leaves of Garcinia intermedia and heartwood of Calophyllumbrasiliense. Biol. Pharm. Bull. 2004, 27, 141–143. [Google Scholar] [CrossRef] [PubMed]
  32. Liu, C.; Ho, P.C.; Cheng, F.; Sethi, G.; Zhi, L. Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects. Cancer Lett. 2015, 362, 8–14. [Google Scholar] [CrossRef] [PubMed]
  33. Vo, H.T.; Ngo, N.T.; Bui, T.Q.; Pham, H.D.; Nguyen, L.D. Geranylated tetraoxygenated xanthones from the pericarp of Garcinia pedunculata. Phytochem. Lett. 2015, 13, 119–122. [Google Scholar] [CrossRef]
  34. Tang, Z.Y.; Xia, Z.X.; Qiao, S.P.; Jiang, C.; Shen, G.R.; Cai, M.X.; Tang, X.Y. Four new cytotoxic xanthones from Garcinia nujiangensis. Fitoterapia 2015, 102, 109–114. [Google Scholar] [CrossRef] [PubMed]
  35. Farombi, E.O.; Owoeye, O. Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoid. Int. J. Environ. Res. Public Health 2011, 8, 2533–2555. [Google Scholar] [CrossRef]
  36. Antia, B.S.; Pansanit, A.; Ekpa, O.D.; Ekpe, U.J.; Mahidol, C.; Kittakoop, P. α-Glucosidase inhibitory, aromatase inhibitory, and antiplasmodial activities of a biflavonoid GB1 from Garcinia kola stem bark. Planta Med. 2010, 76, 276–277. [Google Scholar] [CrossRef]
  37. Guo, J.; Yuan, Y.; Lu, D.; Du, B.; Xiong, L.; Shi, J.; Yang, L.; Liu, W.; Yuan, X.; Zhang, G.; et al. Two natural products, trans-phytol and (22E)-ergosta-6,9,22-triene-3β,5α,8αtriol, inhibit the biosynthesis of estrogen in human ovarian granulosa cells by aromatase (CYP19). Toxicol. Appl. Pharm. 2014, 279, 23–32. [Google Scholar] [CrossRef]
  38. Castardo, J.A.; Prudente, A.S.; Ferreira, J.; Guimarães, C.L.; Delle Monache, F.; Cechinel Filho, V.; Otuki, M.F.; Cabrini, D.A. Anti-inflammatory effects of hydroalcoholic extract and two biflavonoids from Garcinia gardneriana leaves in mouse paw oedema. J. Ethnopharmacol. 2008, 118, 405–411. [Google Scholar] [CrossRef]
  39. Coelho, L.P.; Serra, M.F.; Pires, A.L.D.A.; Cordeiro, R.S.B.; Silva, P.M.R.; Dos Santos, M.H.; Martins, M.A. 7-Epiclusianone, a tetraprenylated benzophenone, relaxes airways mooth muscle through activation of the nitric oxide-cGMP pathway. J. Pharm. Exp. 2008, 327, 206–214. [Google Scholar] [CrossRef]
  40. Arwa, P.S.; Zeraik, M.L.; Ximenes, V.F.; da Fonseca, L.M.; Bolzani, V.D.A.S.; Siqueira Silva, D.H. Redox-active bioflavonoids from Garcinia brasiliensis as inhibitors of neutrophil oxidative burst and human erythrocyte membrane damage. J. Ethnopharmacol. 2015, 174, 410–418. [Google Scholar] [CrossRef]
  41. Gontijo, V.S.; Judice, W.A.S.; Codonho, B.; Pereira, I.O.; Assis, D.M.; Januário, J.P.; Caroselli, E.E.; Juliano, M.A.; de Carvalho-Dosatti, A.; Marques, M.J.; et al. Leishmanicidal, antiproteolytic and antioxidant evaluation of natural bioflavonoids isolated from Garcinia brasiliensis and their semi synthetic derivatives. Eur. J. Medchem. 2012, 58, 613–623. [Google Scholar] [CrossRef] [PubMed]
  42. Gontijo, V.S.; de Souza, T.C.; Rosa, I.A.; Soares, M.G.; da Silva, M.A.; Vilegas, W.; Viegas, C.J.; Dos-Santos, M.H. Isolation and evaluation of the antioxidant activity of phenolic constituents of the Garcinia brasiliensis epicarp. Food Chem. 2012, 132, 1230–1235. [Google Scholar] [CrossRef] [PubMed]
  43. Neves, J.S.; Coelho, L.P.; Cordeiro, R.S.B.; Veloso, M.P.; Silva, P.M.R.; Dos Santos, M.H.; Martins, M.A. Antianaphylactic properties of 7-epiclusianone, a tetraprenylated benzophenone isolated from Garcinia. brasiliensis. Planta Med. 2007, 73, 644–649. [Google Scholar] [CrossRef]
  44. Jantan, I.; Saputri, F.C. Benzophenones and xanthones from Garcinia cantleyana var. cantleyana and their inhibitory activities on human low-density lipoprotein oxidation and platelet aggregation. Phytochemistry 2012, 80, 58–63. [Google Scholar] [CrossRef] [PubMed]
  45. Murata, R.M.; Yatsuda, R.; Dos-Santos, M.H.; Kohn, L.K.; Martins, F.T.; Nagem, T.J.; Alencar, S.M.; Carvalho, J.E.; Rosalen, P.L. Antiproliferative effect of benzophenones and their influence on cathepsin activity. Phytother. Res. 2010, 24, 379–383. [Google Scholar] [CrossRef] [PubMed]
  46. Naldoni, F.J.; Claudino, A.L.R.; Cruz, J.W.; Chavasco, J.K.; Faria e Silva, P.M.; Veloso, M.P.; Dos-Santos, M.H. Antimicrobial activity of benzophenones and extracts from the fruits of Garcinia brasiliensis. J. Med. Food 2009, 12, 403–407. [Google Scholar] [CrossRef]
  47. Figueiredo, S.A.; Vilela, F.M.; da Silva, C.A.; Cunha, T.M.; Dos-Santos, M.H.; Fonseca, M.J. In vitro and in vivo photoprotective/photochemopreventive potential of Garcinia brasiliensis epicarp extract. J. Photochem. Photobiol. B 2014, 131, 65–73. [Google Scholar] [CrossRef]
  48. Sales, L.; Pezuk, J.A.; Borges, K.S.; Brassesco, M.S.; Scrideli, C.A.; Tone, L.G.; dos Santos, M.H.; Ionta, M.; de Oliveira, J.C. Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma. BMC Complementary Altern. Med. 2015, 15, 393. [Google Scholar] [CrossRef] [PubMed]
  49. Castro, A.P.; De Mattos, A.C.; Pereira, N.A.; Anchieta, N.F.; Silva, M.S.; Dias, D.F.; Silva, C.A.; Barros, G.V.; Souza, R.L.; Dos Santos, M.H.; et al. Potent schistosomicidal constituents from Garcinia brasiliensis. Planta Med. 2015, 81, 733–741. [Google Scholar] [CrossRef] [PubMed]
  50. Moreira, M.E.C.; Natal, D.I.G.; Toledo, R.C.L.; Ramirez, N.M.; Ribeiro, S.M.R.; Benjamin, L.A.; Oliveira, L.L.; Rodrigues, D.A.; Antônio, J.D.; Veloso, M.P. Bacupari peel extracts (Garcinia brasiliensis) reduce high-fat diet-induced obesity in rats. J. Funct. Foods 2017, 29, 143–153. [Google Scholar] [CrossRef]
  51. Santos, M.H.; Nagem, T.J.; Oliveira, T.T.; Braz-Filho, R. 7-Epiclusianone, the new tetraprenylated benzophenone and others chemical constituents from the fruits of Rheediagardneriana. Química Nova 1999, 22, 654–660. [Google Scholar] [CrossRef]
  52. Ferreira, R.O.; Carvalho, M.G.; Silva, T.M.S. Ocorrência de biflavonoides em Clusiaceae: Aspectos químicos e farmacológicos. Química Nova 2012, 35, 2271–2277. [Google Scholar] [CrossRef]
  53. Guimarães, C.L.; Otuki, M.F.; Beirith, A.; Cabrini, D.A.A. review on the therapeutic potential of Garcinia gardneriana. Dynamis 2004, 12, 6–12. [Google Scholar]
  54. Asinelli, M.E.C.; de Souza, M.C.; Mourão, K.S.M. Fruit ontogeny of Garcinia gardneriana (Planch. & amp; Triana) Zappi (Clusiaceae). Acta Botbras 2011, 25, 43–52. [Google Scholar]
  55. Campos, P.M.; Horinouchi, C.D.S.; Prudente, A.S.; Cechinel-Filho, V.; Cabrini, D.A.; Otuki, M.F. Effect of Garcinia garderiana (Planchon and Triana) Zappi hydroalcoholic extract on melanogenesis in B16F10 melanoma cells. J. Ethnopharmacol. 2013, 148, 199–204. [Google Scholar] [CrossRef] [PubMed]
  56. Solano, F.; Briganti, S.; Picardo, M.; Ghanem, G. Hypopigmenting agents: An updated review on biological, chemical and clinical aspects. Pigment Cell Res. 2006, 19, 550–571. [Google Scholar] [CrossRef]
  57. Subeki, M.H.; Yamasaki, M.; Yamato, O.; Maede, Y.; Katakura, K.; Suzuki, M.; Trimurningsih, C.; Yoshihara, T. Effects of central kalimantan plant extracts on intraerythrocytic Babesia gibsoni in culture. J. Vet. Med. Sci. 2004, 66, 871–874. [Google Scholar] [CrossRef]
  58. Verdi, L.G.; Pizzolatti, M.G.; Montanher, A.B.P.; Brighente, I.M.C.; Smânia, J.A.; Smânia, E.F.A.; Simionatto, E.L.; Monache, F.D. Antibacterial and brine shrimp lethality tests of biflavonoids and derivatives of Rheedia gardneriana. Fitoterapia 2004, 75, 360–363. [Google Scholar] [CrossRef]
  59. Otuki, M.F.; Bernardi, C.A.; Prudente, A.S.; Laskoski, K.; Gomig, F.; Horinouchi, C.D.S.; Guimarães, C.L.; Ferreira, J.; Monache, F.D.; Cechinel-Filho, V.; et al. Garcinia gardneriana (Planchon and Triana) Zappi. (Clusiaceae) as a topical anti-inflammatory alternative for cutaneous inflammation. Basic Clin. Pharm. 2011, 109, 56–62. [Google Scholar] [CrossRef]
  60. Melo, M.S.; Quintans, J.S.; Araújo, A.A.; Duarte, M.C.; Bonjardim, L.R.; Nogueira, P.C.; Moraes, V.R.; Araújo-Júnior, J.X.; Ribeiro, E.A.; Quintans-Júnior, L.J. A systematic review for anti-inflammatory property of Clusiaceae family: A preclinical approach. J. Evid. Based Complementary Altern. Med. 2014, 2014, 960258. [Google Scholar]
  61. Cechinel-Filho, V. Advances and perspectives in the field of active natural products: Studies conducted at Niqfar/Univali. Quim Nova 2000, 23, 680–684. [Google Scholar]
  62. Luzzi, R.; Guimarães, C.L.; Verdi, L.G.; Simionatto, E.L.; Monache, F.D.; Yunes, R.A.; Floriani, A.E.O.; Oliveira, A.E.; Filho, V.C. Isolation of biflavonoids with analgesic activity from Rheedia gardneriana leaves. Phytomedicine 1997, 4, 139–142. [Google Scholar] [CrossRef]
  63. Cechinel-Filho, V.; da Silva, K.L.; de Souza, M.M.; Oliveira, A.E.; Yunes, R.A.; Guimarães, C.L.; Verdi, L.G.; Simionatto, E.L.; Delle-Monache, F. I3-Naringenin-II8-4′OMeeriodictyol: A new potential analgesic agent isolated from Rheedia gardneriana leaves. Z. Nat. C. 2000, 55, 820–823. [Google Scholar]
  64. Campos, P.M.; Prudente, A.S.; Horinouchi, C.D.; Cechinel-Filho, V.; Fávero, G.M.; Cabrini, D.A.; Otuki, M.F. Inhibitory effect of GB-2a (I3-naringenin-II8-eriodictyol) on melanogenesis. J. Ethnopharmacol. 2015, 174, 224–229. [Google Scholar] [CrossRef] [PubMed]
  65. Recalde-Gil, A.M.; Klein-Júnior, L.; Salton, J.; Bordignon, S.; Cechinel-Filho, V.; Matté, C.; Henriques, A. Aromatase (CYP19) inhibition by biflavonoids obtained from the branches of Garcinia gardneriana (Clusiaceae). Z. Nat. C. J. Biosci. 2019, 10, 279–282. [Google Scholar] [CrossRef]
  66. Mundugaru, R.; Varadharajan, M.C.; Basavaiah, R. Hepatoprotective activity of fruit extract of Garcinia pedunculata. Bangladesh. J. Pharm. 2014, 9, 483–487. [Google Scholar]
  67. Sarma, R.; Devi, R. Ethnopharmacological survey of Garcinia pedunculata Roxb. Fruit six different districts of Assam, India. Int. J. Pharm. Sci. Invent. 2015, 4, 20–28. [Google Scholar]
  68. Kagyung, R.; Gajurel, P.R.; Rethy, P.; Singh, B. Ethnomedicinal plants used for gastro-intestinal diseases by adi tribes of dehang-debang biosphere reserve in arunachal pradesh. Indian J. Tradit. Knowl. 2010, 9, 496–501. [Google Scholar]
  69. Vo, H.T.; Nguyen, T.N.T.; Nguyen, H.T.; Do, K.Q.; Connolly, J.D.; Mass, G.; HeilmannWerz, J.U.R.; Pham, D.H.; Nguyen, D.L.H. Cytotoxic tetraoxygenated xanthones from the bark of Garcinia schomburgkiana. Phytochem. Lett. 2012, 5, 553–557. [Google Scholar] [CrossRef]
  70. Sahu, A.; Das, B.; Chatterjee, A. Polyisoprenylated benzophenones from Garcinia pedunculata. Phytochemistry 1989, 28, 1233–1235. [Google Scholar] [CrossRef]
  71. Ravi, M.; Febin, J.; Shrinidhi, R.; Lipika, D.; Sudhakara, B.; Ravishankar, B. Anti-inflammatory activity of aqueous extract of fruits of Garcinia pedunculata in experimental animals. Am. J. Pharma. Tech. Res. 2014, 4, 3–6. [Google Scholar]
  72. Ravi, M.; Senthilkumar, S.; Padmaja, U.K.; Sudhakara, B. Cardio protective activity of fruits extract of Garcinia pedunculata. Bangladesh. J. Pharm. 2016, 11, 5–9. [Google Scholar]
  73. Jayaprakasha, G.K.; Jena, B.S.; Sakariah, K.K. Improved liquid chromatographic method for determination of organic acids in leaves, pulp, fruits, and rinds of Garcinia. J. Aoac. Int. 2003, 86, 1063–1068. [Google Scholar] [CrossRef] [PubMed]
  74. Ito, C.; Itoigawa, M.; Miyamoto, Y. A new biflavonoid from Calophyllumpanciflorum with antitumor-promoting activity. J. Nat. Prod. 1999, 12, 1668–1671. [Google Scholar] [CrossRef] [PubMed]
  75. Mudoi, T.; Deka, D.C.; Devi, R. In vitro antioxidant activity of Garcinia pedunculata, an indigenous fruit of North Eastern (NE) region of India. Int. J. Pharmtech. Res. 2012, 4, 334–342. [Google Scholar]
  76. Negi, P.S.; Jayaprakasha, G.K.; Jena, B.S. Antibacterial activity of the extracts from the fruit rinds of Garcinia cowa and Garcinia pedunculata against food borne pathogens and spoilage bacteria. LWT-Food Sci. Technol. 2008, 41, 1857–1861. [Google Scholar] [CrossRef]
  77. Sarma, R.; Kumari, S.; Elancheran, R.; Deori, M.; Devi, R. Polyphenol rich extract of Garcinia pedunculata fruit attenuates the hyperlipidemia induced by high fat diet. Front Pharm. 2016, 7, 294. [Google Scholar] [CrossRef]
  78. Mitcheva, M.; Kondeva, M.; Vitcheva, V.; Nedialkov, P.; Kitanov, G. Effect of benzophenones from hypericum annulatum on carbon tetrachloride-induced toxicity in freshly isolated rat hepatocytes. Redox. Rep. 2006, 11, 3–8. [Google Scholar] [CrossRef]
  79. Hung, W.L.; Liu, C.-M.; Lai, C.S.; Ho, C.T.; Pan, M.H. Inhibitory effect of garcinol against 12-O-tetradecanoylphorbol 13- acetate-induced skin inflammation and tumorigenesis in mice. J. Funct. Foods 2015, 18, 432–444. [Google Scholar] [CrossRef]
  80. Mundugaru, R.; Sivanesan, S.K.; Udaykumar, P.; Joy, F.; Narayana, S.K.K.; Rajakrishnan, L.; Al Farhan, A.H.; Jacob, T.; Rajagopal, R.; Hisham, S.M. Quality standardization and nephroprotective effect of Garcinia pedunculata Roxb. Fruit extract. Indian J. Pharm. Educ. 2017, 51, 713–721. [Google Scholar] [CrossRef]
  81. Paul, S.; Ali, M.Y.; Rumpa, N.E.; Tanvir, E.M.; Hossen, M.S.; Saha, M.; Bhoumik, N.C.; Gan, S.H.; Khalil, M.I. Assessment of toxicity and beneficiary effects of Garcinia pedunculata on the hematological, biochemical, and histological homeostasis in rats. J. Evid. Based Complementary Altern. Med. 2017, 2017, 1–11. [Google Scholar] [CrossRef]
  82. Ali, M.Y.; Paul, S.; Tanvir, E.M.; Hossen, M.S.; Rumpa, N.N.; Saha, M.; Bhoumik, N.C.; Islam, M.A.; Hossain, M.S.; Alam, N.; et al. Antihyperglycemic, antidiabetic, and antioxidant effects of Garcinia pedunculata in rats. J. Evid. Based Complementary Altern. Med. 2017, 2017, 1–15. [Google Scholar] [CrossRef] [PubMed]
  83. Mundugaru, R.; Udaykumar, P.; Kumar, S.; Narayana, S.K.K.; Jacob, T.; AlFarhan, A.H.; Rajakrishnan, L. Protective effect of garcinia pedunculata fruit rind in acetic acid induced ulcerative colitis. Farmacia 2019, 67, 160–166. [Google Scholar] [CrossRef]
  84. Anu-Aravind, A.P.; Asha, K.R.T.; Rameshkumar, K.B. Phytochemical analysis and antioxidant potential of the leaves of Garcinia travancorica Bedd. Nat. Prod. Res. 2016, 30, 232–236. [Google Scholar] [CrossRef] [PubMed]
  85. Semwal, R.B.; Semwal, D.K.; Vermaak, I.; Viljoen, A. A comprehensive scientific overview of Garcinia cambogia. Fitoterapia 2015, 102, 134–148. [Google Scholar] [CrossRef] [PubMed]
  86. Klein-Junior, L.C.; Antunes, M.V.; Linden, R.; Vasques, C.A.R. Quantification of (-)hydroxycitric acid in marketed extracts of Garcinia cambogia by high performance liquid chromatography. Lat. Am. J. Pharm. 2010, 29, 835–838. [Google Scholar]
  87. Di-Micco, S.; Masullo, M.; Bandak, A.F.; Berger, J.M.; Riccio, R.; Piacente, S.; Bifulco, G. Garcinol and related polyisoprenylated benzophenones as topoisomerase II inhibitors: Biochemical and molecular modeling studies. J. Nat. Prod. 2019, 82, 2768–2779. [Google Scholar] [CrossRef]
  88. Saito, M.; Ueno, M.; Ogino, S.; Kubo, K.; Nagata, J.; Takeuchi, M. High dose of Garcinia cambogia is effective in suppressing fat accumulation in developing male Zucker obese rats, but highly toxic to the testis. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2005, 43, 411–419. [Google Scholar] [CrossRef]
  89. Duke, J.; Bogenschutz-Godwin, M.; DuCellier, J.; Duke, P.A. Handbook of Medicinal Herbs, 2nd ed.; CRC Press: Boca Raton, FL, USA, 2002; p. 481. [Google Scholar]
  90. Iwu, M.M. Handbook of African Medicinal Plants; CRC Press: London, UK, 1993; pp. 183–184. [Google Scholar]
  91. Ho, C.K.; Huang, Y.L.; Chen, C.C. Garcinone E, a xanthone derivative, has potent cytotoxic effect against hepatocellular carcinoma cell lines. Planta Med. 2002, 68, 975–979. [Google Scholar] [CrossRef] [PubMed]
  92. Nakatani, K.; Atsumi, M.; Arakawa, T.; Oosawa, K.; Shimura, S.; Nakahata, N.; Ohizumi, Y. Inhibitions of histamine release and prostaglandin E2 synthesis by mangosteen, a Thai medicinal plant. Biol. Pharm. Bull. 2002, 25, 1137–1141. [Google Scholar] [CrossRef]
  93. Mahendran, P.; Sabitha, K.E.; Devi, C.S. Prevention of H-Clethanol induced gastric mucosal injury in rats by Garcinia cambogia extract and its possible mechanism of action. Indian J. Exp. Biol. 2002, 40, 58–62. [Google Scholar] [PubMed]
  94. Iwu, M.W.; Duncan, A.R.; Okunji, C.O. New antimicrobials of plant origin. In Perspectives on New Crops and New Uses; Janick, J., Ed.; ASHS Press: Alexandria, VA, USA, 1999; pp. 457–462. [Google Scholar]
  95. Chen, S.X.; Wan, M.; Loh, B.N. Active constituents against HIV-1 protease from Garcinia mangostana. Planta Med. 1996, 62, 381–382. [Google Scholar] [CrossRef] [PubMed]
  96. Sripradha, R.; Magadi, S.G. Efficacy of Garcinia cambogia on body weight, inflammation and glucose tolerance in high fat fed male wistar rats. J. Clin. Diagn. Res. 2015, 9, 1–4. [Google Scholar] [CrossRef] [PubMed]
  97. Mahendran, P.; Vanisree, A.J.; Devi, C.S. The antiulcer activity of Garcinia cambogia extract against indomethacin induced gastric ulcer in rats. Phytother. Res. 2002, 16, 80–83. [Google Scholar] [CrossRef] [PubMed]
  98. Mahendran, P.; Devi, C.S. Effect of Garcinia cambogia extract on lipids and lipoprotein composition in dexamethasone administered rats. Indian J. Physiolpharmacol. 2001, 45, 345–350. [Google Scholar]
  99. Kim, M.S.; Kim, J.K.; Kwon, D.Y.; Park, R. Anti-adipogeniceffects of Garcinia extract on the lipid droplet accumulationand the expression of transcription factor. Biofactors 2004, 22, 193–196. [Google Scholar] [CrossRef]
  100. Ishihara, K.; Oyaizu, S.; Onuki, K.; Lim, K.; Fushiki, T. Chronic (-)-hydroxycitrate administration spares carbohydrate utilization and promotes lipid oxidation during exercise in mice. J. Nutr. 2000, 130, 2990–2995. [Google Scholar] [CrossRef]
  101. Koshy, A.S.; Vijayalakshmi, N.R. Impact of certain flavonoidson lipid profiles-potential action of Garcinia cambogia flavonoids. Phytother. Res. 2001, 15, 395–400. [Google Scholar] [CrossRef]
  102. Reis, S.B.; Oliveira, C.C.; Acedo, S.C.; Miranda, D.D.; Ribeiro, M.L.; Pedrazzoli, J., Jr.; Gambero, A. Attenuation of colitis injury in rats using Garcinia cambogia extract. Phytother. Res. 2009, 23, 324–329. [Google Scholar] [CrossRef]
  103. Oluyemi, K.A.; Omotuyi, I.O.; Jimoh, O.R.; Adesanya, O.A.; Saalu, C.L.; Josiah, S.J. Erythropoietic and anti-obesity efects of Garcinia cambogia (bitter kola) in Wistar rats. Biotechnol. Appl. Biochem. 2007, 46, 69–72. [Google Scholar]
  104. Sharma, K.; Kang, S.; Gong, D.; Oh, S.H.; Park, E.Y.; Oak, M.H.; Yi, E. Combination of Garcinia cambogia extract and pear pomace extract additively suppresses adipogenesis and enhances lipolysis in 3T3-L1 Cells. Pharm. Mag. 2018, 14, 220–226. [Google Scholar]
  105. Sripradha, R.; Sridhar, M.G.; Maithilikarpagaselvi, N. Antihyperlipidemic and antioxidant activities of the ethanolic extract of Garcinia cambogia on high fat diet-fed rats. J. Complementary Integr. Med. 2016, 13, 9–16. [Google Scholar] [CrossRef] [PubMed]
  106. Maia-Landim, A.; Ramirez, J.M.; Lancho, C.; Poblador, M.S.; Lancho, J.L. Long-term effects of Garcinia cambogia/Glucomannan on weight loss in people with obesity, PLIN4, FTO and Trp64Arg polymorphisms. BMC omplementary Altern. Med. 2018, 18, 1–26. [Google Scholar] [CrossRef] [PubMed]
  107. Hayamizu, K.; Hirakawa, H.; Oikawa, D.; Nakanishi, T.; Takagi, T.; Tachibana, T.; Furuse, M. Effect of Garcinia cambogia extract on serum leptin and insulin in mice. Fitoterapia 2003, 74, 267–273. [Google Scholar] [CrossRef]
  108. Preuss, H.G.; Rao, C.V.; Garis, R.; Bramble, J.D.; Ohia, S.E.; Bagchi, M.; Bagchi, D. An overview of the safety and efficacy of a novel, natural (-)-hydroxycitric acid extract (HCA-SX) for weight management. J. Med. 2004, 35, 33–48. [Google Scholar] [PubMed]
  109. Lopez, A.M.; Kornegay, J.; Hendrickson, R.G. Serotonin toxicity associated with Garcinia cambogia over-the-counter supplement. J. Med. Toxicol. 2014, 4, 399–401. [Google Scholar] [CrossRef]
  110. Haber, S.L.; Awwad, O.; Phillips, A.; Park, A.E.; Pham, T.M. Garcinia cambogia for weight loss. Am. J. Health Syst. Pharm. 2018, 75, 17–22. [Google Scholar] [CrossRef]
  111. Jena, B.S.; Jayaprakasha, G.K.; Singh, R.P.; Sakariah, K.K. Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia. J. Agric. Food Chem. 2002, 50, 10–22. [Google Scholar] [CrossRef]
  112. Stallings, W.C.; Blount, J.F.; Srere, P.A.; Glusker, J.P. Structural studies of hydroxycitrates and their relevance to certain enzymatic mechanisms. Arch. Biochem. Biophys. 1979, 193, 431–448. [Google Scholar] [CrossRef]
  113. Ohia, S.E.; Opere, C.A.; LeDay, A.M.; Bagchi, M.; Bagchi, D.; Stohs, S.J. Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Mol. Cell Biochem. 2002, 238, 89–103. [Google Scholar] [CrossRef]
  114. Asghar, M.; Monjok, E.; Kouamou, G.; Ohia, S.E.; Bagchi, D.; Lokhandwala, M.F. Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats. Mol. Cell Biochem. 2007, 304, 93–99. [Google Scholar] [CrossRef] [PubMed]
  115. Preuss, H.G.; Garis, R.I.; Bramble, J.D.; Bagchi, D.; Bagchi, M.; Rao, C.V.; Satyanarayana, S. Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control. Int. J. Clin. Pharm. Res. 2005, 25, 133–144. [Google Scholar]
  116. Li, L.; Peng, M.; Ge, C.; Yu, L.; Ma, H. Hydroxycitric acid reduced lipid droplets accumulation via decreasing acetyl-coa supply and accelerating energy metabolism in cultured primary chicken hepatocytes. Cell Physiolbiochem. 2017, 43, 812–831. [Google Scholar] [CrossRef] [PubMed]
  117. Nisha, V.M.; Priyanka, A.; Anusree, S.S.; Raghu, K.G. (-)-Hydroxycitric acid attenuates endoplasmic reticulum stress-mediated alterations in 3T3-L1 adipocytes by protecting mitochondria and downregulating inflammatory markers. Free Radic. Res. 2014, 48, 1386–1396. [Google Scholar] [CrossRef] [PubMed]
  118. Pittler, M.H.; Schmidt, K.; Ernst, E. Adverse events of herbal food supplements for body weight reduction: Systematic review. Obes. Rev. 2005, 2, 93–111. [Google Scholar] [CrossRef]
  119. Narasimha, A.; Shetty, P.H.; Nanjundaswamy, M.H.; Viswanath, B.; Math, S.B. Hydroxycut—dietary supplements for weight loss: Can they induce mania? Aust. N. Z. J. Psychiatry 2013, 47, 1205–1206. [Google Scholar] [CrossRef] [PubMed]
  120. Beecheno, M.; Budd, S.; Mohan, T. Natural weight loss supplements—are they psychoactive? Aust. N. Z. J. Psychiatry 2016, 50, 700–701. [Google Scholar] [CrossRef]
  121. Cotovio, G.; Olivera-Maia, A.J. Hypomania induced by a Garcinia cambogia supplement. Aust. N. Z. J. Psychiatry 2016, 51, 641–642. [Google Scholar] [CrossRef]
  122. Crescioli, G.; Lombardi, N.; Bettiol, A.; Marconi, E.; Risaliti, F.; Bertoni, M.; Ippolito, F.M.; Maggini, V.; Gallo, E.; Firenzuoli, F.; et al. Acute liver injury following Garcinia cambogia weight-loss supplementation: Case series and literature review. Intern. Emerg. Med. 2018, 13, 857–872. [Google Scholar] [CrossRef]
  123. Licata, A.; Minissale, M.G. Weight-loss supplementation and acute liver failure: The case of Garcinia cambogia. Intern. Emerg. Med. 2018, 13, 833–835. [Google Scholar] [CrossRef]
  124. Lunsford, K.E.; Bodzin, A.S.; Reino, D.C.; Wang, H.; Basuttil, R. Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation. World J. Gastroenterol. 2016, 22, 10071–10076. [Google Scholar] [CrossRef] [PubMed]
  125. Sharma, A.; Akagi, E.; Njie, A.; Goyal, S.; Arsene, S.; Krishnamoorthy, G.; Ehrinpreis, M. Acute hepatitis due to Garcinia cambogia extract, an herbal weight loss supplement. Case Rep. Gastrointest. Med. 2018, 9606171. [Google Scholar]
  126. Hendrickson, B.P.; Shaikh, N.; Occhiogrosso, M.; Penzner, J.B. Mania induced by Garcinia cambogia: A case series. Prim. Care Companion. Cns. Disord. 2016, 18, 104088. [Google Scholar] [CrossRef] [PubMed]
  127. Cho, H.K.; Han, Y.S.; Park, J.M. Ocular complications of Garcinia cambogia extract diet pills: Case report. Eur. J. Ophthalmol. 2019, 1–6. [Google Scholar] [CrossRef] [PubMed]
  128. Grigos, A.; Benmoussa, J.; Sandhu, J.; Chaucer, B.; Clarke, M. Acute pancreatitis secondary to Garcinia cambogia; the unknown cost of herbal supplements. J. Pancreas. 2016, 17, 316–317. [Google Scholar]
  129. Bystrak, T.; Cervera-Hernandez, M.E.; Reddy, N.; King, Z.; Bratberg, J. Garcinia cambogia, Diabetic Ketoacidosis, and Pancreatitis. Rhode Isl. Med. J. 2017, 100, 48–50. [Google Scholar]
  130. Li, J.W.; Bordelon, P. Hydroxycitric acid dietary supplement-related herbal nephropathy. Am. J. Med. 2011, 124, 5–6. [Google Scholar] [CrossRef]
  131. Batcioglu, K.; Gul, M.; Uyumlu, A.B.; Esrefoglu, M. Liver lipid peroxidation and antioxidant capacity in cerulein-induced acute pancreatitis. Braz. J. Med. Biol. Res. 2009, 42, 776–782. [Google Scholar] [CrossRef]
  132. Corey, R.; Werner, K.T.; Singer, A.; Moss, A.; Smith, A.; Noelting, J.; Rakela, J. Acute liver failure associated with Garcinia cambogia use. Ann. Hepatol. 2016, 15, 123–126. [Google Scholar] [CrossRef]
  133. Kim, Y.J.; Choi, M.S.; Park, Y.B.; Kim, S.R.; Lee, M.K.; Jung, U.J. Garcinia cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation. World J. Gastroenterol. 2013, 19, 4689–5701. [Google Scholar] [CrossRef]
  134. Ovalle-Magallanes, B.; Eugenio, D.; Pedraza-Chaverri, J. Medicinal properties of mangosteen (Garcinia mangostana L.): A comprehensive update. Food Chem. Toxicol. 2017, 109, 102–122. [Google Scholar] [CrossRef] [PubMed]
  135. Allen, S.F.; Godley, R.W.; Evron, J.M.; Heider, A.; Nicklas, J.M.; Thomas, M.P. Acute necrotizing eosinophilic myocarditis in a patient taking Garcinia cambogia extract successfully treated with high-dose corticosteroids. Can. J. Cardiol. 2014, 30, 1732.e13-5. [Google Scholar] [CrossRef] [PubMed]
  136. Ibrahim, S.R.M.; Mohamed, G.A.; Khayat, M.T.; Ahmed, S.; Abo-Haded, H.; Alshali, K.Z. Mangostanaxanthone VIIII, a new xanthone from Garcinia mangostana pericarps, α-amylase inhibitory activity, and molecular docking studies. Rev. Bras. Farm. 2019, 29, 206–212. [Google Scholar] [CrossRef]
  137. Hosakatte, N.; Dandin, V.; Dalawai, D.; Park, S.Y.; Paek, K. Bioactive compounds from garcinia fruits of high economic value for food and health. Phytochem. Spr. Nature 2018, 1, 1–28. [Google Scholar]
  138. Abdallah, H.M.; El-Bassossy, H.M.; Mohamed, G.A.; El-Halawany, A.M.; Alshali, K.Z.; Banjar, Z.M. Mangostana xanthones III and IV: Advanced glycation end-product inhibitors from the pericarp of Garcinia mangostana. J. Nat. Med. 2017, 71, 216–226. [Google Scholar] [CrossRef]
  139. Obolskiy, D.; Pischel, I.; Siriwatanametanon, N.; Heinrich, M. Garcinia mangostana L.: A phytochemical and pharmacological review. Phytother. Res. 2009, 31, 110–118. [Google Scholar] [CrossRef]
  140. Pedraza-Chaverri, J.; Cárdenas-Rodríguez, N.; Orozco-Ibarra, M.; Pérez-Rojas, J.M. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem. Toxicol. 2008, 46, 3227–3239. [Google Scholar] [CrossRef]
  141. Yoshikawa, M.; Harada, E.; Miki, A.; Tsukamoto, K.; Liang, S.; Yamahara, J. Antioxidant constituents from the fruit hulls of mangosteen (Garcinia mangostana L.) originating in Vietnam. Yakugakuzasshi. J. Pharm. Soc. Jpn. 1994, 114, 129–133. [Google Scholar] [CrossRef]
  142. Jung, H.-A.; Su, B.-N.; Keller, W.J.; Mehta, R.G.; Kinghorn, A.D. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J. Agric. Food. Chem. 2006, 54, 2077–2082. [Google Scholar] [CrossRef]
  143. Chairungsrilerd, N.; Furukawa, K.I.; Ohta, T.; Nozoe, S.; Ohizumi, Y. Histaminergic and serotonergic receptor blocking substances from the medicinal plant Garcinia mangostana. Planta Med. 1996, 62, 471–472. [Google Scholar] [CrossRef]
  144. Chen, L.-G.; Yang, L.-L.; Wang, C.-C. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem. Toxicol. 2008, 46, 688–693. [Google Scholar] [CrossRef] [PubMed]
  145. Chomnawang, M.T.; Surassmo, S.; Wongsariya, K.; Bunyapraphatsara, N. Antibacterial activity of Thai medicinal plants against methicillin-resistant Staphylococcus aureus. Fitoterapia 2009, 80, 102–104. [Google Scholar] [CrossRef] [PubMed]
  146. Oberholzer, I.; Möller, M.; Holland, B.; Dean, O.; Berk, M.; Harvey, B. Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: A bio-behavioral study in the flinders sensitive line rat. Metab. Brain Dis. 2018, 33, 467–480. [Google Scholar] [CrossRef] [PubMed]
  147. Sakagami, Y.; Iinuma, M.; Piyasena, K.; Dharmaratne, H. Antibacterial activity of α-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Phytomedicine 2005, 12, 203–208. [Google Scholar] [CrossRef] [PubMed]
  148. Nakagawa, Y.; Iinuma, M.; Naoe, T.; Nozawa, Y.; Akao, Y. Characterized mechanism of α-mangostin-induced cell death: Caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorg. Med. Chem. 2007, 15, 5620–5628. [Google Scholar] [CrossRef]
  149. Fang, Y.; Su, T.; Qiu, X.; Mao, P.; Xu, Y.; Hu, Z.; Zhang, Y.; Zheng, X.; Xie, P.; Liu, Q. Protective effect of alpha-mangostin against oxidative stress induced-retinal cell death. Sci. Rep. 2016, 6, 21018. [Google Scholar] [CrossRef]
  150. Tjahjani, S.; Widowati, W.; Khiong, K.; Suhendra, A.; Tjokropranoto, R. Antioxidant properties of Garcinia mangostana L (mangosteen) rind. Procedia. Chem. 2014, 13, 198–203. [Google Scholar] [CrossRef]
  151. Tousian, H.; Razavi, B.M.; Hosseinzadeh, H. Alpha-mangostin decreased cellular senescence in human umbilical vein endothelial cells. DARU J. Pharm. Sci. 2019, 1–11. [Google Scholar] [CrossRef]
  152. Bumrungpert, A.; Kalpravidh, R.W.; Chitchumroonchokchai, C.; Chuang, C.C.; West, T.; Kennedy, A.; McIntosh, M. Xanthones from mangosteen prevent lipopolysaccharide-mediated inflammation and insulin resistance150 in primary cultures of human adipocytes. J. Nutr. 2009, 139, 1185–1191. [Google Scholar] [CrossRef]
  153. Jariyapongskul, A.; Areebambud, C.; Suksamrarn, S.; Mekseepralard, C. Alpha-mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes rats. Biomed. Res. Int. 2015, 785826. [Google Scholar] [CrossRef]
  154. Karim, N.; Rahman, M.A.; Changlek, S.; Tangpong, J. Short-time administration of xanthone from Garcinia mangostana fruit pericarp attenuates the hepatotoxicity and renotoxicity of type II diabetes mice. J. Am. Coll. Nutr. 2019, 1–10. [Google Scholar] [CrossRef] [PubMed]
  155. Li, D.; Liu, Q.; Lu, X.; Li, Z.; Wang, C.; Leung, C.-H.; Wang, Y.; Peng, C.; Lin, L. α-Mangostin remodels visceral adipose tissue inflammation to ameliorate age-related metabolic disorders in mice. Aging 2019, 23, 11084–11110. [Google Scholar] [CrossRef]
  156. Husen, S.A.; Winarni, D.; Khaleyla, F.; Kalqutny, S.H.; Ansori, A.N.M. Activity assay of mangosteen (Garcinia mangostana L.) pericarp extract for decreasing fasting blood cholesterol level and lipid peroxidation in type-2 diabetic mice. AIP Conf. Proc. 2017, 1888, 020026. [Google Scholar]
  157. Husen, S.A.; Khaleyla, F.; Ansori, A.N.M.; Susilo, R.J.K.; Winarni, D. Antioxidant activity assay of alpha-mangostin for amelioration of kidney structure and function in diabetic mice. Adv. Soc. Sci. Educ. Hum. Res. (Assehr) 2018, 98, 84–88. [Google Scholar]
  158. Manaharan, T.; Palanisamy, U.D.; Ming, C.H. Tropical plant extracts as potential antihyperglycemic agents. Molecules 2012, 17, 5915–5923. [Google Scholar] [CrossRef] [PubMed]
  159. Ansori, A.; Fadholly, A.; Hayaza, S.; Susilo, R.; Inayatilllah, B.; Winarni, D.; Husen, S. A review on medicinal properties of mangosteen (Garcinia mangostana L.). Res. J. Pharm. Technol. 2020, 13, 974–982. [Google Scholar] [CrossRef]
  160. Husen, S.A.; Winarni, D.; Salamun; Ansori, A.N.M.; Susilo, R.J.K.; Hayaza, S. Hepatoprotective effect of gamma-mangostin for amelioration of impaired liver structure and function in streptozotocin-induced diabetic mice. IOP Conf. Ser. Earth Environ. Sci. 2019, 217, 1–10. [Google Scholar] [CrossRef]
  161. Aisha, A.F.; Abu-Salah, K.M.; Ismail, Z.; Majid, A.M. In vitro and in vivo anti-colon cancer effects of Garcinia mangostana xanthones extract. BMC Complementary Altern. Med. 2012, 12, 104–112. [Google Scholar] [CrossRef]
  162. Matsumoto, K.; Akao, Y.; Ohguch, K.; Ito, T.; Tanaka, T.; Iinuma, M.; Nozawa, Y. Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells. Bioorganic Med. Chem. 2005, 21, 6064–6069. [Google Scholar] [CrossRef]
  163. Wang, J.J.; Sanderson, B.J.; Zhang, W. Cytotoxic effect of xanthones from pericarp of the tropical fruit mangosteen (Garcinia mangostana Linn.) on human melanoma cells. Food Chem. Toxicol. 2011, 49, 2385–2391. [Google Scholar] [CrossRef]
  164. Suksamrarn, S.; Komutiban, O.; Ratananukul, P.; Chimnoi, N.; Lartpornmatulee, N.; Suksamrarn, A. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem. Pharm. Bull. 2006, 3, 301–305. [Google Scholar] [CrossRef] [PubMed]
  165. Muhamad-Adyab, N.S.; Rahmat, A.; Abdul-Kadir, N.A.A.; Jaafar, H.; Shukri, R.; Ramli, N.S. Mangosteen (Garcinia mangostana) flesh supplementation attenuates biochemical and morphological changes in the liver and kidney of high fat diet-induced obese rats. BMC Complementary Altern. Med. 2019, 19, 299–344. [Google Scholar] [CrossRef] [PubMed]
  166. Bumrungpert, A.; Kalpravidh, R.W.; Chuang, C.C.; Overman, A.; Martinez, K.; Kennedy, A.; McIntosh, M. Xanthones from Mangosteen inhibit inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. J. Nutr. 2010, 140, 842–847. [Google Scholar] [CrossRef] [PubMed]
  167. Xie, Z.; Sintara, M.; Chang, T.; Ou, B. Daily consumption of a mangosteen-based drink improves in vivo antioxidant and anti-inflammatory biomarkers in healthy adults: A randomized, double-blind, placebo-controlled clinical trial. Food Sci. Nutr. 2015, 3, 342–348. [Google Scholar] [CrossRef] [PubMed]
  168. Raybaudi-Massilia, R.M.; Mosqueda-Melgar, J.; Martín-Belloso, O. Antimicrobial activity of malic acid against Listeria monocytogenes, Salmonella enteritidis and Escherichia coli O157:H7 in apple, pear and melon juices. Food Control. 2009, 2, 105–112. [Google Scholar] [CrossRef]
  169. Yang, R.; Li, P.; Li, N.; Zhang, Q.; Bai, X.; Wang, L.; Yan, J. Xanthones from the Pericarp of Garcinia mangostana. Molecules 2017, 22, 683. [Google Scholar] [CrossRef]
  170. Xu, T.; Deng, Y.; Zhao, S.; Shao, Z. A new xanthone from the pericarp of Garcinia mangostana. J. Chem. Res. 2016, 1, 10–11. [Google Scholar] [CrossRef]
  171. Wang, W.; Liao, Y.; Huang, X.; Tang, C.; Cai, P. A novel xanthone dimer derivative with antibacterial activity isolated from the bark of Garcinia mangostana. Nat. Prod. Res. 2017, 15, 1769–1774. [Google Scholar] [CrossRef]
  172. Mohamed, G.A.; Al-Abd, A.M.; El-Halawany, A.M.; Abdallah, H.M.; Ibrahim, S.R.M. New xanthones and cytotoxic constituents from Garcinia mangostana fruit hulls against human hepatocellular, breast, and colorectal cancer cell lines. J. Ethnopharm. 2017, 198, 302–312. [Google Scholar] [CrossRef]
  173. Tran, T.H.; Le Huyen, T.; Tran, T.M.; Nguyen, T.A.; Pham, T.B.; Nguyen Tien, D. A new megastigmanesulphoglycoside and polyphenolic constituents from pericarps of Garcinia mangostana. Nat. Prod. Res. 2016, 30, 1598–1604. [Google Scholar] [CrossRef]
  174. Shahat, A.A.; Ismail, S.I.; Hammouda, F.M.; Azzam, S.A.; Lemière, G.; De Bruyne, T.; Vlietinck, A. Anti-HIV activity of flavonoids and proanthocyanidins from Crataegussinaica. Phytomedicine 1998, 5, 133–136. [Google Scholar] [CrossRef]
Figure 1. Bioactive compounds of Garcinia brasiliensis.
Figure 1. Bioactive compounds of Garcinia brasiliensis.
Molecules 25 04513 g001
Figure 2. Bioactive compounds of Garcinia gardneriana.
Figure 2. Bioactive compounds of Garcinia gardneriana.
Molecules 25 04513 g002
Figure 3. Bioactive compounds of Garcinia pedunculata.
Figure 3. Bioactive compounds of Garcinia pedunculata.
Molecules 25 04513 g003
Figure 4. Bioactive compounds of Garcinia cambogia.
Figure 4. Bioactive compounds of Garcinia cambogia.
Molecules 25 04513 g004
Figure 5. Bioactive compounds of Garcinia mangostana.
Figure 5. Bioactive compounds of Garcinia mangostana.
Molecules 25 04513 g005
Table 1. Compounds present in different parts of Garcinia brasiliensis and their related activities.
Table 1. Compounds present in different parts of Garcinia brasiliensis and their related activities.
Garcinia Brasiliensis
CompoundsPlant PartActivity
α-Ylangene; α-Copaene; β-Bourbonene; β-Elemene; β-Caryophyllene; β-Gurjunene; Aromadendrene; α-Humulene; Drima-7,9(11)-diene; y-Muurolene-10; Germacrene D; β-Selinene; Viridiflorene; α-Muurolene; γ-Cadinene; cis-Calamenene; Cadina-1,4-diene; α-Cadinene; α-Calacorene; Longicamphenylone; Ledol; Spathulenol; Globulol; Salvial-4(14)-en-1-one; Guaiol; Viridiflorol; Humuleneepoxide II; 1,10-Diepicubenol; 1-Epicubenol; Cubenol; Cedr-8(15)-en-9a–ol; Torreyol; Selin-11-en-4a-ol; α-Cadinol; Khusinol; Cadalene; 14-Oxy-α-muurolene.Peel [31]Anti-inflammatory and antioxidant [21] (correlation of all compounds)
FukugetinFruit [43]Analgesic [52], antioxidant [43]
FukugisideFruit [43]Analgesic [52], antioxidant [12]
morelloflavone-4′’’-O-β-d-glycosideFruit [43]Antioxidant [12]
AmentoflavoneLeaf [41]Anti-inflammatory and antioxidant [41]
Podocarpusflavone ALeaf [41]Anti-inflammatory and antioxidant [41]
GarcinolLeaf [41]Anti-inflammatory and antioxidant [41], anticancer, antiparasitic, action in nervous system [24]
7-epiclusianoneLeaf [22]/Fruit [47]Antinociceptive and anti-inflamatory [22], antimicrobial [47], anticarcinogenic [49], leishmanicidal [21], schistosomicidal [50]
Organic Acid
Galic acidLeaf [41]Anti-inflammatory and antioxidant [41]
ProcyanidineLeaf [41]Anti-inflammatory and antioxidant [41]
Guttiferone-ASeeds [47]/Fruits [21]Antimicrobial [47], photoprotective, and photochemopreventive [20] Leishmanicidal [21]
1,3,6,7-tetrahydroxyxanthoneFruit [43]Antioxidant [43]
Table 2. List of compounds presented in different parts of Garcinia gardneriana and related activities.
Table 2. List of compounds presented in different parts of Garcinia gardneriana and related activities.
Garcinia Gardneriana
CompoundsPlant PartActivity
GB-2aLeaf [64], branches [59]Antiedematogenic [64], anti-inflammatory [64], anticancer [65]
Gb-2a-7-O-glucosideBranches [59]Anticancer [65]
VolkensiflavoneLeaf [52]Analgesic [52]
FukugentinLeaf [52]Analgesic [52], anti-inflammatory [59], antioxidant [43]
FukugisideLeaf [52]Analgesic [52], antioxidant [52]
GB-2a-II-4′-OMeLeaf [52]Analgesic [52]
CompoundPlant PartActivity
EpicatechinLeaf [58]Antibacterial [58]
CompoundPlant PartActivity
SitosterolFruits [52]Anti-inflammatory and anticancer [31]
stigmasterolFruits [52]Anti-inflammatory and anticancer [31]
7-epiclusanonePeel [52]Antinociceptive and anti-inflammatory [22], antimicrobial [47], anticarcinogenic [49], leishmanicidal [21], schistossomicidal [50]
α-copenePeel [52]-
α-muurolenePeel [52]-
γ-cadinenePeel [52]-
CadinenePeel [52]-
Oleanolic acidPeel [52]-
Table 3. List of compounds present in different parts of Garcinia pedunculata and related activities.
Table 3. List of compounds present in different parts of Garcinia pedunculata and related activities.
Garcinia Pedunculata
CompoundsPlant PartActivity
1,3,6,7-tetrahydroxyxanthoneHeartwood [19]Antioxidant [43]
1,3,5,7-tetrahydroxyxanthoneHeartwood [19]Inhibits oxidation of LDL-c [45]
1,5-dihydroxy-3-methoxy-6′,6′-dimethyl-2H-pyrano(2′,3′:6,7)-4-(3-methylbut-2-enyl)xanthonePeel [69]-
1,5-dihydroxy-3-methoxy-4-(3-methylbut-2-enyl)xanthonePeel [69]-
Dulxanthone APeel [69]-
GarbogiolPeel [69]Inhibition of α-glucosidade [10]
Pedunxanthone-APeel [69]-
Pedunxanthone-BPeel [69]-
Pedunxanthone-CPeel [69]-
Pedunxanthone-DPericarp [33]Anticancer [65]
Pedunxanthone-EPericarp [33]Anticancer [65]
Pedunxanthone-FPericarp [33]Anticancer [65]
1,6-dihydroxy-7-methoxy-8-(3-methyl-2-butenyl)-6′,6′-dimethylpyrane-(2′,3′:3,2)-xanthonePericarp [33]-
6-O-demethyloliverixanthonePericarp [33]-
Fuscaxanthone APericarp [33]Cytotoxic [16]
CowaninPericarp [33]Antimalarial [65]
NorcowaninPericarp [33]Antiplasmodic [65]
CowanolPericarp [33]Antimalarial [65]
α-mangostinPericarp [33]-
MangostanolPericarp [33]-
3-isomangostinPericarp [33]-
1,7-dihydroxyxanthonePericarp [33]-
PedunculolDry fruits [70]Antioxidant [16]
IsogarcinolDry fruits [70]Anticancer, anti-inflammatory, antiparasitic, action in nervous system [24]
GarcinolDry fruits [70]Anticancer, anti-inflammatory, antiparasitic, action in nervous system [24]
2,4,6,3′,5′-pentahydroxybenzophenoneHeartwood [19]-
GB-1aHeartwood [19]Antioxidant [84]
volkensiflavoneHeartwood [19]Antitumoral [74]
Oleanolic acidPeel [69]-
Table 4. List of compounds presented in different parts of Garcinia cambogia and their related activities.
Table 4. List of compounds presented in different parts of Garcinia cambogia and their related activities.
Garcinia Cambogia
CompoundsPlant PartActivity
GarbogiolRoots [85]Inhibition of α-glucosid [10]
Rheedia xanthone APeel [85]-
Oxy-guttiferone iFruits [85]-
Oxy-guttiferone kFruits [85]-
Oxy-guttiferone k2Fruits [85]-
Oxy-guttiferone mFruits [85]-
garcinolPeel [85]Anticancer, anti-inflammatory, antiparasitic, action on nervous system [24]
isogarcinolPeel [85]Anticancer, anti-inflammatory, antiparasitic, action on nervous system [24]
Guttiferone iFruits [85]-
Guttiferone nFruits [85]-
Guttiferone jFruits [85]-
Guttiferone kFruits [85]Topoisomerase II inhibitor [87]
Guttiferone mFruits [85]Topoisomerase II inhibitor [87]
Organic Acids
Heterocyclic aminesFruits [85]Antiobesity [137]
Tartaric acidFruits [85]-
Citric acidFruits [85]-
Malic acidFruits [85]Antimicrobial [138]
GarcinialactoneFruits [85]-
Table 5. List of compounds presented in different parts of Garcinia mangostana and their related activities.
Table 5. List of compounds presented in different parts of Garcinia mangostana and their related activities.
Garcinia Mangostana
CompoundsPlant PartActivity
α-MangostinPericarp, whole fruit, stem, arils, and seed [159]Antibacterial, antifungal, antihistamine, antiobesity, anticancer [159], neuroprotective, antineoplastic [134], antioxidant [168]
β-MangostinPericarp, whole fruit, stem [159]Antiparasitic, hypoglycemic, antiobesity [134], antioxidant [168]
γ-MangostinPericarp, whole fruit [159]Antibacterial, anti-inflammatory, antihistamine, anticancer, hepatoprotective [159], antineoplastic, hypoglycemic, antiobesity, neuroprotective [134]
(16E)-1,6-Dihydroxy-8-(3-hydroxy-3-methylbut-1-enyl)-3,7-dimethoxy-2-(3-methylbut-2-enyl)-xanthoneNot stated [159]-
(16E)-1-Hydroxy-8-(3-hydroxy-3-methylbut-1-enyl)-3,6,7-trimethoxy-2-(3methylbut-2-enyl)-xanthoneWhole fruit [159]-
1,2-Dihydro-1,8,10-trihydroxy-2-(2-hydroxypropan-2-yl)-9-(3-methylbut-2-enyl)furo [3,2-a]xanthen-11-oneHeartwood [159]-
1,3,6,7-Tetrahydroxy-xanthonePericarp [159]-
1,3,6,7-Tetrahydroxy-2,8-(3-methyl-2-butenyl)-xanthone-P1Pericarp [159]-
1,3,6-Trihydroxy-7-methoxy-2,8-(3-methyl-2-butenyl)-xanthone-P2Leaves [159]-
1,3,8-Trihydroxy-4-methyl-2,7-diisoprenylxanthoneHeartwood [159]-
1,3,7-Trihydroxy-2,8-di-(3-methylbut-2-enyl)-xanthonLeaves [159], Pericarp [169]-
1,3-Dihydroxy-2-(2-hydroxy-3-methylbut-3-enyl)-6,7-dimethoxy-8-(3-methylbut-2-enyl)-xanthoneHeartwood [159]-
1,5-Dihydroxy-2-(3-methylbut-2-enyl)-3-methoxy-xanthoneHeartwood, stem [159]-
1,5-dihydroxy-2-isopentyl-3-methoxy xanthoneHeartwood [159]-
1,5,8-Trihydroxy-3-methoxy-2-(3-methylbut-2-enyl) xanthoneHeartwood [159], Pericarp [159]-
1,6-Dihydroxy-2-(2-hydroxy-3-methylbut-3-enyl)-3,7-dimethoxy-8-(3-methylbut-2-enyl)-xanthonePericarp [159]-
1,6-Dihydroxy-3-methoxy-2-(3-methyl-2-buthenyl)-xanthonePericarp [159]-
1,6-Dihydroxy-3,7-dimethoxy-2-(3-methylbut-2-enyl)-8-(2-oxo-3-methylbut-3-enyl)-xanthoneWhole fruit [159]-
1,6-Dihydroxy-3,7-dimethoxy-2-(3-methylbut-2-enyl)-xanthoneHeartwood [159]-
1,6-Dihydroxy-8-(2-hydroxy-3-methylbut-3-enyl)-3,7-dimethoxy-2-(3-methylbut-2-enyl)-xanthoneHeartwood [159]-
1,7-Dihydroxy-2-(3-methylbut-2-enyl)-3-methoxy-xanthonePericarp [159]-
1,7-dihydroxy-2-isopentyl-3-methoxy xanthonePericarp [159]-
11-Hydroxy-1-isomangostinNot stated [159]-
1-Hydroxy-2-(2-hydroxy-3-methylbut-3-enyl)-3,6,7-trimethoxy-8-(3-methylbut-2-enyl)-xanthoneHeartwood [159]-
1-IsomangostinPericarp [159]-
1-Isomangostin hydratePericarp [159]-
2-(γ,γ-Dimethylallyl)-1,7-dihydroxy-3-methoxyxanthonePericarp, arils [159]-
2,3,6,8-Tetrahydroxy-1-isoprenylxanthoneNot stated [159]-
2,8-bis-(γ,γ-Dimethyallyl)-1,3,7-trihydroxyxanthoneArils [159]-
3-IsomangostinPericarp [159]Hypoglycemic, antiobesity, neuroprotective [134]
3-Isomangostin hydratePericarp [159]-
5,9-Dihydroxy-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-enyl)-2H,6Hpyrano-(3,2,6)-xanthene-6-oneFruit hull [159]-
6-Deoxy-7-demethylmangostaninWhole fruit [159]
6-methoxy–bis pyrano xanthonePericarp [159]Antioxidant [170]
6-O-MethylmangostaninNot stated [159]
7-O-Demethyl mangostaninPericarp [159]Anticancer [169]
8-DeoxygartaninPericarp, whole fruit [159]-
8-HydroxycudraxanthonePericarp [159]-
9-hydroxycalabaxanthoneBark [171]Neuroprotective [134]
BR-Xanthone-APericarp [159]-
BR-Xanthone BPericarp [159]-
CalabaxanthoneArils [159]-
CratoxyxanthonePericarp, stem, whole fruit [169]-
CudraxanthonePericarp [159]-
DemethylcalabaxanthoneWhole fruit, arils, seed [159]Antibacterial [159]
Dulxanthone-ABark [171]Antibacterial [171]
Garcimangosone AFruit hull [159]-
Garcimangosone BPericarp [159]-
Garcimangosone CPericarp [159]-
GarciniafuranHeartwood [159]Neuroprotective [134]
Garcinone BPericarp, whole fruit [159]-
Garcinone CWhole fruit [159]Neuroprotective [134]
Garcinone DPericarp, whole fruit, stem [159]Antibacterial [161], neuroprotective [134], antioxidant [47]
Garcinone EPericarp, whole fruit [159]-
Garcinoxanthone-ANot stated [134]Antinociceptive, anti-inflammatory [134]
Garcinoxanthone-BNot stated [134]Antinociceptive, anti-inflammatory [134]
Garcinoxanthone-CNot stated [134]Antioxidant [46], antinociceptive, anti-inflammatory [134]
Garcinoxanthone-dNot stated [134]Antinociceptive, anti-inflammatory [134]
Garcinoxanthone-ENot stated [134]Antinociceptive, anti-inflammatory [138], antibacterial [171]
Garcinoxanthone-FNot stated [134]Antinociceptive, anti-inflammatory [134]
Garcinoxanthone-GNot stated [134]Antinociceptive, anti-inflammatory [134]
GarmoxanthoneBark [171]Antibacterial [171]
GartaninPericarp, whole fruit [159]Antineoplastic, hypoglycemic, antiobesity, neuroprotective [134], antioxidant [170]
IsogarcinolNot stated [134]Antinociceptive, anti-inflammatory [134], antibacterial [43]
MangosharinStem [159]-
Mangostaxanthone-IPericarp [133]α-amylase inhibitor [136]
Mangostaxanthone-IIPericarp [133]α-amylase inhibitor [136]
Mangostaxanthone-IIIPericarp [168]AGE* inhibitor, antioxidant [168]
Mangostaxanthone-IVFruits [172] Pericarp [164]AGE* inhibitor, antioxidant [168]
Mangostaxanthone-VFruits [172]-
Mangostaxanthone-VIFruits [172]-
Mangostaxanthone-VIIPericarp [136]-
Mangostanaxanthone-VIIIIPericarp [136]α-Amylase inhibitory [136]
MangostanatePericarp [172]-
GlucosidaMangostaninPericarp [159]Antibacterial [159]
MangostanolWholefruit, stem [159]-
MangostenolPericarp [159]-
Mangostenone APericarp [159]-
Mangostenone BPericarp [159]-
MangostenoneCWhole fruit [159]Hypoglycemic, antiobesity [134]
Mangostenone DWhole fruit [159]Hypoglycemic, antiobesity [134]
Mangostenone EWhole fruit [159]
Mangostenone FNot stated [134]α-glucosidase inhibitor, antineoplastic [134]
MangostinonePericarp, whole fruit [159]-
Nigrolineaxanthone TBark [171]-
Nor-mangostinFruits [172]-
RubraxantonePericarp [168]Antioxidant [168]
Smeathxanthone APericarp [159]-
ThwaitesixanthoneWhole fruit [159]-
Tovophyllin APericarp [159]-
Tovophyllin BPericarp [159]-
Toxyloxanthone A (trapezifolixanthone)Pericarp [159]-
trapezifolixanthonePericarp [169]-
1,7-dihydroxyxanthonePericarp [159]-
EuxanthonePericarp [159]-
Caloxanthone APericarp [159]-
MacluraxanthonePericarp [159]-
Mangostingone [7-methoxy-2-(3-isoprenyl)-8-(3-methyl-2-oxo-3-buthenyl)-1,3,6-trihydroxyxanthonePericarp [159]-
Garcimangosone DPericarp [159]-
MaclurinPericarp, heartwood [159]-
maclurin-6-O-β-d-glucopyranosidePericarp [134]Hypoglycemic, antiobesity [134]
KolanonePericarp [159]-
ChrysantheminPericarp [159]-
Cyanidin-3-O-glucosideNot stated [159]-
proanthocyanidin A2Pericarp [173]Anti-HIV [174]
EpicatehinPericarp [159]Antidiabetic, antioxidant [173], hypoglycemic, antiobesity [134]
Aromadendrin-8-C-β-d-glucopyranosidePericarp [134]Hypoglycemic, antiobesity [134]
4-O-sulpho-β-d-glucopyranosylabscisatePericarp [173]Antioxidant [173]
Back to TopTop